KR20180014985A - Novel organic compounds derivatives and organic light-emitting diode therewith - Google Patents
Novel organic compounds derivatives and organic light-emitting diode therewith Download PDFInfo
- Publication number
- KR20180014985A KR20180014985A KR1020160098513A KR20160098513A KR20180014985A KR 20180014985 A KR20180014985 A KR 20180014985A KR 1020160098513 A KR1020160098513 A KR 1020160098513A KR 20160098513 A KR20160098513 A KR 20160098513A KR 20180014985 A KR20180014985 A KR 20180014985A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- group
- substituted
- carbon atoms
- unsubstituted
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title claims abstract description 33
- 150000001875 compounds Chemical class 0.000 claims abstract description 353
- 239000000126 substance Substances 0.000 claims abstract description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 182
- 125000001424 substituent group Chemical group 0.000 claims description 112
- 239000010410 layer Substances 0.000 claims description 102
- 125000003118 aryl group Chemical group 0.000 claims description 54
- 125000000217 alkyl group Chemical group 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 32
- 125000001072 heteroaryl group Chemical group 0.000 claims description 26
- 229910052805 deuterium Inorganic materials 0.000 claims description 18
- 230000005525 hole transport Effects 0.000 claims description 17
- 229910052799 carbon Inorganic materials 0.000 claims description 16
- 239000012044 organic layer Substances 0.000 claims description 16
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 14
- -1 phosphoryl group Chemical group 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 125000004104 aryloxy group Chemical group 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000005842 heteroatom Chemical group 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 10
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 125000002723 alicyclic group Chemical group 0.000 claims description 9
- 125000005104 aryl silyl group Chemical group 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 125000003367 polycyclic group Chemical group 0.000 claims description 9
- 229940126639 Compound 33 Drugs 0.000 claims description 8
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 8
- 150000001721 carbon Chemical group 0.000 claims description 8
- 229940125904 compound 1 Drugs 0.000 claims description 8
- 125000005647 linker group Chemical group 0.000 claims description 8
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 claims description 7
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims description 7
- 125000000304 alkynyl group Chemical group 0.000 claims description 7
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical group [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000001769 aryl amino group Chemical group 0.000 claims description 4
- 125000005165 aryl thioxy group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 125000004185 ester group Chemical group 0.000 claims description 4
- 125000005549 heteroarylene group Chemical group 0.000 claims description 4
- 238000005286 illumination Methods 0.000 claims description 4
- 125000006760 (C2-C60) alkynylene group Chemical group 0.000 claims description 3
- 125000006761 (C6-C60) arylene group Chemical group 0.000 claims description 3
- 125000005377 alkyl thioxy group Chemical group 0.000 claims description 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000005264 aryl amine group Chemical group 0.000 claims description 3
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 3
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 3
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 3
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims description 3
- 239000002346 layers by function Substances 0.000 claims description 3
- 125000002950 monocyclic group Chemical group 0.000 claims description 3
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims description 3
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical group [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 claims description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 2
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 claims description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims description 2
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims description 2
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 claims description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims description 2
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims description 2
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims description 2
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 claims description 2
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 claims description 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 claims description 2
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 claims description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims description 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims description 2
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 claims description 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 claims description 2
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims description 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 claims description 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 claims description 2
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 claims description 2
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 claims description 2
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 claims description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims description 2
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 claims description 2
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 claims description 2
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 claims description 2
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 claims description 2
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 claims description 2
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims description 2
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 claims description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 claims description 2
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 claims description 2
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 claims description 2
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 claims description 2
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 claims description 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims description 2
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 claims description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims description 2
- 229940126657 Compound 17 Drugs 0.000 claims description 2
- 229940127007 Compound 39 Drugs 0.000 claims description 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims description 2
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 claims description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims description 2
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims description 2
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims description 2
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims description 2
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 claims description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims description 2
- 229940125773 compound 10 Drugs 0.000 claims description 2
- 229940125797 compound 12 Drugs 0.000 claims description 2
- 229940126543 compound 14 Drugs 0.000 claims description 2
- 229940125758 compound 15 Drugs 0.000 claims description 2
- 229940126142 compound 16 Drugs 0.000 claims description 2
- 229940125782 compound 2 Drugs 0.000 claims description 2
- 229940125810 compound 20 Drugs 0.000 claims description 2
- 229940126086 compound 21 Drugs 0.000 claims description 2
- 229940126208 compound 22 Drugs 0.000 claims description 2
- 229940125833 compound 23 Drugs 0.000 claims description 2
- 229940125961 compound 24 Drugs 0.000 claims description 2
- 229940125846 compound 25 Drugs 0.000 claims description 2
- 229940125851 compound 27 Drugs 0.000 claims description 2
- 229940127204 compound 29 Drugs 0.000 claims description 2
- 229940126214 compound 3 Drugs 0.000 claims description 2
- 229940125877 compound 31 Drugs 0.000 claims description 2
- 229940125878 compound 36 Drugs 0.000 claims description 2
- 229940125807 compound 37 Drugs 0.000 claims description 2
- 229940127573 compound 38 Drugs 0.000 claims description 2
- 229940126540 compound 41 Drugs 0.000 claims description 2
- 229940125936 compound 42 Drugs 0.000 claims description 2
- 229940125844 compound 46 Drugs 0.000 claims description 2
- 229940127271 compound 49 Drugs 0.000 claims description 2
- 229940125898 compound 5 Drugs 0.000 claims description 2
- 229940126545 compound 53 Drugs 0.000 claims description 2
- 229940127113 compound 57 Drugs 0.000 claims description 2
- 229940125900 compound 59 Drugs 0.000 claims description 2
- 229940126179 compound 72 Drugs 0.000 claims description 2
- 238000005137 deposition process Methods 0.000 claims description 2
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 claims description 2
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 claims description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims description 2
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 1
- OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 claims 1
- SRKGZXIJDGWVAI-GVAVTCRGSA-M (e,3r)-7-[6-tert-butyl-4-(4-fluorophenyl)-2-propan-2-ylpyridin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)C1=NC(C(C)(C)C)=CC(C=2C=CC(F)=CC=2)=C1\C=C\C(O)C[C@@H](O)CC([O-])=O SRKGZXIJDGWVAI-GVAVTCRGSA-M 0.000 claims 1
- ZYZCALPXKGUGJI-DDVDASKDSA-M (e,3r,5s)-7-[3-(4-fluorophenyl)-2-phenyl-5-propan-2-ylimidazol-4-yl]-3,5-dihydroxyhept-6-enoate Chemical compound C=1C=C(F)C=CC=1N1C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C(C)C)N=C1C1=CC=CC=C1 ZYZCALPXKGUGJI-DDVDASKDSA-M 0.000 claims 1
- ISMDILRWKSYCOD-GNKBHMEESA-N C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O Chemical compound C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O ISMDILRWKSYCOD-GNKBHMEESA-N 0.000 claims 1
- FDBYIYFVSAHJLY-UHFFFAOYSA-N resmetirom Chemical compound N1C(=O)C(C(C)C)=CC(OC=2C(=CC(=CC=2Cl)N2C(NC(=O)C(C#N)=N2)=O)Cl)=N1 FDBYIYFVSAHJLY-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 96
- 230000015572 biosynthetic process Effects 0.000 description 95
- 238000003786 synthesis reaction Methods 0.000 description 94
- 239000000463 material Substances 0.000 description 31
- 238000002347 injection Methods 0.000 description 26
- 239000007924 injection Substances 0.000 description 26
- 239000000203 mixture Substances 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 12
- 238000004440 column chromatography Methods 0.000 description 11
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000002019 doping agent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 8
- JYNKVVLDGGRVFE-UHFFFAOYSA-N 4-bromo-2-iodobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1I JYNKVVLDGGRVFE-UHFFFAOYSA-N 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 229910052796 boron Inorganic materials 0.000 description 6
- 229910052732 germanium Inorganic materials 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 5
- 238000004770 highest occupied molecular orbital Methods 0.000 description 5
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000011368 organic material Substances 0.000 description 5
- 238000004528 spin coating Methods 0.000 description 5
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 125000005110 aryl thio group Chemical group 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- UCCUXODGPMAHRL-UHFFFAOYSA-N 1-bromo-4-iodobenzene Chemical compound BrC1=CC=C(I)C=C1 UCCUXODGPMAHRL-UHFFFAOYSA-N 0.000 description 3
- BQBXKWGMPUCSQV-UHFFFAOYSA-N 2,5-dibromobenzaldehyde Chemical compound BrC1=CC=C(Br)C(C=O)=C1 BQBXKWGMPUCSQV-UHFFFAOYSA-N 0.000 description 3
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 150000001975 deuterium Chemical group 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthene Chemical compound C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 229910001148 Al-Li alloy Inorganic materials 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 229910018068 Li 2 O Inorganic materials 0.000 description 2
- 229910019015 Mg-Ag Inorganic materials 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 150000001454 anthracenes Chemical group 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000000732 arylene group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical compound C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000007857 hydrazones Chemical class 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 150000002902 organometallic compounds Chemical class 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 238000002207 thermal evaporation Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 238000001771 vacuum deposition Methods 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- JWJQEUDGBZMPAX-UHFFFAOYSA-N (9-phenylcarbazol-3-yl)boronic acid Chemical compound C12=CC=CC=C2C2=CC(B(O)O)=CC=C2N1C1=CC=CC=C1 JWJQEUDGBZMPAX-UHFFFAOYSA-N 0.000 description 1
- 125000006743 (C1-C60) alkyl group Chemical group 0.000 description 1
- 125000006749 (C6-C60) aryl group Chemical group 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OIAQMFOKAXHPNH-UHFFFAOYSA-N 1,2-diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC=C1C1=CC=CC=C1 OIAQMFOKAXHPNH-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XJKSTNDFUHDPQJ-UHFFFAOYSA-N 1,4-diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=C(C=2C=CC=CC=2)C=C1 XJKSTNDFUHDPQJ-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- RJKGJBPXVHTNJL-UHFFFAOYSA-N 1-nitronaphthalene Chemical compound C1=CC=C2C([N+](=O)[O-])=CC=CC2=C1 RJKGJBPXVHTNJL-UHFFFAOYSA-N 0.000 description 1
- IVCGJOSPVGENCT-UHFFFAOYSA-N 1h-pyrrolo[2,3-f]quinoline Chemical group N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 description 1
- YDYNSAUGVGAOLO-UHFFFAOYSA-N 2,6-dibromobenzaldehyde Chemical compound BrC1=CC=CC(Br)=C1C=O YDYNSAUGVGAOLO-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- MDFXJBQEWLCGHP-MFOYZWKCSA-N 2-[2-[(z)-(pyridine-4-carbonylhydrazinylidene)methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC=C1\C=N/NC(=O)C1=CC=NC=C1 MDFXJBQEWLCGHP-MFOYZWKCSA-N 0.000 description 1
- GEQBRULPNIVQPP-UHFFFAOYSA-N 2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole Chemical compound C1=CC=CC=C1N1C2=CC=CC=C2N=C1C1=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=C1 GEQBRULPNIVQPP-UHFFFAOYSA-N 0.000 description 1
- VWVRASTUFJRTHW-UHFFFAOYSA-N 2-[3-(azetidin-3-yloxy)-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(CN1C=C(C(OC2CNC2)=N1)C1=CN=C(NC2CC3=C(C2)C=CC=C3)N=C1)N1CCC2=C(C1)N=NN2 VWVRASTUFJRTHW-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- WWSJZGAPAVMETJ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethoxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCC WWSJZGAPAVMETJ-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- MBHPOBSZPYEADG-UHFFFAOYSA-N 2-bromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC=CC=C3C2=C1 MBHPOBSZPYEADG-UHFFFAOYSA-N 0.000 description 1
- NDOPHXWIAZIXPR-UHFFFAOYSA-N 2-bromobenzaldehyde Chemical compound BrC1=CC=CC=C1C=O NDOPHXWIAZIXPR-UHFFFAOYSA-N 0.000 description 1
- RKVIAZWOECXCCM-UHFFFAOYSA-N 2-carbazol-9-yl-n,n-diphenylaniline Chemical compound C1=CC=CC=C1N(C=1C(=CC=CC=1)N1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 RKVIAZWOECXCCM-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- SKMKJBYBPYBDMN-RYUDHWBXSA-N 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC(F)F)C(N)=NC=C1C1=CC(N2[C@H]3C[C@H](OC3)C2)=NC(N2CC(F)(F)CC2)=N1 SKMKJBYBPYBDMN-RYUDHWBXSA-N 0.000 description 1
- TZZDVPMABRWKIZ-MFTLXVFQSA-N 3-[6-[4-[[1-[4-[(1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl]phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione Chemical compound OC=1C=C2CC[C@@H]([C@@H](C2=CC=1)C1=CC=C(C=C1)N1CCC(CC1)CN1CCN(CC1)C=1C=C2CN(C(C2=CC=1)=O)C1C(NC(CC1)=O)=O)C1=CC=CC=C1 TZZDVPMABRWKIZ-MFTLXVFQSA-N 0.000 description 1
- PBOOZQFGWNZNQE-UHFFFAOYSA-N 3-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC(Br)=C1 PBOOZQFGWNZNQE-UHFFFAOYSA-N 0.000 description 1
- OGGKVJMNFFSDEV-UHFFFAOYSA-N 3-methyl-n-[4-[4-(n-(3-methylphenyl)anilino)phenyl]phenyl]-n-phenylaniline Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 OGGKVJMNFFSDEV-UHFFFAOYSA-N 0.000 description 1
- XWQVQSXLXAXOPJ-QNGMFEMESA-N 4-[[[6-[5-chloro-2-[[4-[[(2r)-1-methoxypropan-2-yl]amino]cyclohexyl]amino]pyridin-4-yl]pyridin-2-yl]amino]methyl]oxane-4-carbonitrile Chemical compound C1CC(N[C@H](C)COC)CCC1NC1=CC(C=2N=C(NCC3(CCOCC3)C#N)C=CC=2)=C(Cl)C=N1 XWQVQSXLXAXOPJ-QNGMFEMESA-N 0.000 description 1
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 description 1
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 1
- PRJHEJGMSOBHTO-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-1-(3-hydroxypropyl)-3-methyl-8-[3-(trifluoromethoxy)phenoxy]purine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=CC(OC(F)(F)F)=C1 PRJHEJGMSOBHTO-UHFFFAOYSA-N 0.000 description 1
- NJIAKNWTIVDSDA-FQEVSTJZSA-N 7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-n-[[(2s)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine Chemical compound C1CN(S(=O)(=O)C)CCC1C1=CC=C(C=2N=C(NC[C@H]3OCCNC3)C3=NC=CN=C3C=2)C=C1 NJIAKNWTIVDSDA-FQEVSTJZSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 description 1
- SCJNYBYSTCRPAO-LXBQGUBHSA-N CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 Chemical compound CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 SCJNYBYSTCRPAO-LXBQGUBHSA-N 0.000 description 1
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical class COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 241000284156 Clerodendrum quadriloculare Species 0.000 description 1
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- DRBWRJPFNOBNIO-KOLCDFICSA-N [(2r)-1-[(2r)-2-(pyridine-4-carbonylamino)propanoyl]pyrrolidin-2-yl]boronic acid Chemical compound N([C@H](C)C(=O)N1[C@@H](CCC1)B(O)O)C(=O)C1=CC=NC=C1 DRBWRJPFNOBNIO-KOLCDFICSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OTKPPUXRIADSGD-PPRNARJGSA-N avoparcina Chemical compound O([C@@H]1C2=CC=C(C(=C2)Cl)OC=2C=C3C=C(C=2O[C@H]2C([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C(C=C2)[C@@H](O)[C@H](C(N[C@H](C(=O)N[C@H]3C(=O)N[C@H]2C(=O)N[C@@H]1C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)C=1C=CC(O)=CC=1)=O)NC(=O)[C@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@H]1C[C@@H](N)[C@@H](O)[C@H](C)O1 OTKPPUXRIADSGD-PPRNARJGSA-N 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Inorganic materials [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- NYENCOMLZDQKNH-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)bismuthanyl trifluoromethanesulfonate Chemical compound [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F NYENCOMLZDQKNH-UHFFFAOYSA-K 0.000 description 1
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Inorganic materials [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- XNKVIGSNRYAOQZ-UHFFFAOYSA-N dibenzofluorene Chemical compound C12=CC=CC=C2C2=CC=CC=C2C2=C1CC1=CC=CC=C12 XNKVIGSNRYAOQZ-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- BFXLJWUGRPGMFU-UHFFFAOYSA-N dipropoxyphosphinothioyl n,n-diethylcarbamodithioate;sulfane Chemical compound S.CCCOP(=S)(OCCC)SC(=S)N(CC)CC BFXLJWUGRPGMFU-UHFFFAOYSA-N 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005597 hydrazone group Chemical group 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Inorganic materials [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 1
- HZZOEADXZLYIHG-UHFFFAOYSA-N magnesiomagnesium Chemical compound [Mg][Mg] HZZOEADXZLYIHG-UHFFFAOYSA-N 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- SJFNDMHZXCUXSA-UHFFFAOYSA-M methoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COC)C1=CC=CC=C1 SJFNDMHZXCUXSA-UHFFFAOYSA-M 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 description 1
- IBHBKWKFFTZAHE-UHFFFAOYSA-N n-[4-[4-(n-naphthalen-1-ylanilino)phenyl]phenyl]-n-phenylnaphthalen-1-amine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C=C1 IBHBKWKFFTZAHE-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000005649 substituted arylene group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ZGNPLWZYVAFUNZ-UHFFFAOYSA-N tert-butylphosphane Chemical compound CC(C)(C)P ZGNPLWZYVAFUNZ-UHFFFAOYSA-N 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- 125000001935 tetracenyl group Chemical group C1(=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C12)* 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- PZJJKWKADRNWSW-UHFFFAOYSA-N trimethoxysilicon Chemical group CO[Si](OC)OC PZJJKWKADRNWSW-UHFFFAOYSA-N 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/24—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
- C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
- C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
- C07C13/62—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with more than three condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H01L51/0067—
-
- H01L51/0073—
-
- H01L51/0074—
-
- H01L51/5056—
-
- H01L51/5072—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/15—Hole transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
Abstract
Description
본 발명은 신규한 유기 화합물 및 이를 포함하는 유기 발광 소자에 관한 것으로서, 보다 상세하게는 유기발광소자로 사용되는 경우에 고효율, 장수명 및 저전압 구동 등의 소자 특성을 구현할 수 있는 신규한 유기 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel organic compound and an organic light emitting device including the organic compound. More particularly, the present invention relates to a novel organic compound capable of realizing device characteristics such as high efficiency, long life and low- To an organic light emitting device.
유기 발광 소자(organic light emitting diode, OLED)는 자기 발광 현상을 이용한 디스플레이로서, 시야각이 크고 액정 디스플레이에 비해 경박, 단소해질 수 있고, 빠른 응답 속도 등의 장점을 가지고 있어 풀-컬러(full-color) 디스플레이 또는 조명으로의 응용이 기대되고 있다.The organic light emitting diode (OLED) is a display using a self-luminous phenomenon. The organic light emitting diode (OLED) has a wide viewing angle and is thinner and lighter than a liquid crystal display and has a fast response speed. ) Applications for display or illumination are expected.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말하며, 상기 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. Generally, an organic light emitting phenomenon refers to a phenomenon in which an organic material is used to convert electrical energy into light energy. The organic light emitting device using the organic light emitting phenomenon typically has a structure including an anode, an anode, and an organic layer between the anode and the cathode.
여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등으로 이루어질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기 발광 소자는 자발광, 고휘도, 고효율, 낮은 구동전압, 넓은 시야각, 높은 콘트라스트, 고속 응답성 등의 특성을 갖는 것으로 알려져 있다.Here, in order to enhance the efficiency and stability of the organic light emitting device, the organic material layer may have a multi-layered structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic light emitting device, holes are injected in the anode, electrons are injected into the organic layer in the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out. Such an organic light emitting device is known to have characteristics such as self-emission, high luminance, high efficiency, low driving voltage, wide viewing angle, high contrast, and high speed response.
유기 발광 소자에서 유기물층으로 사용되는 재료는 기능에 따라, 발광 재료와 전하수송 재료, 예컨대 정공주입 재료, 정공수송 재료, 전자수송 재료, 전자주입 재료 등으로 분류될 수 있고, 필요에 따라 전자차단층 또는 정공차단층 등이 부가될 수 있다. The material used as the organic material layer in the organic light emitting device may be classified into a light emitting material and a charge transporting material such as a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material, Or a hole blocking layer may be added.
이들 중에서, 전자 수송층용 재료에 관한 종래기술로서, 전자 수송능력과 정공 저지능력이 우수하며 발광 효율이 우수하며 박막 상태에서의 안정성이 높은 유기 화합물을 제조하기 위해 공개특허공보 제10-2012-0104204호(2012.09.20)에서는 치환된 안트라센환 구조에 피리도인돌 유도체가 결합된 유기화합물에 관해 기재되어 있으며, 일본공개특허공보 특개2010-168363 호(2010.08.05)에서는 외부 양자 효율 및 구동 전압의 특성이 우수한 특성을 가지는, 피리딘 나프틸기를 가지는 안트라센 유도체에 관해 기재되어 있다. Of these, in order to produce an organic compound having excellent electron transporting ability and hole blocking ability, excellent luminous efficiency and high stability in a thin film state, as a prior art related to an electron transporting layer material, it is disclosed in Korean Patent Publication No. 10-2012-0104204 (2012.09.20) describes an organic compound in which a pyridoindole derivative is bonded to a substituted anthracene ring structure, and in JP-A-2010-168363 (2010.08.05), an external quantum efficiency and a driving voltage Discloses an anthracene derivative having a pyridine naphthyl group, which has excellent characteristics.
한편, 정공 수송층에 관한 종래기술로서, 등록특허공보 제10-1074193호(공고일: 2011.10.14)에서는 정공 수송층 화합물로서 카바졸 구조에 적어도 하나의 벤젠 고리가 축합된 고어 구조를 갖는 화합물을 이용한 유기 발광 소자가 개시되어 있고, 또한, 등록특허공보 제10-1455156호(공고일: 2014.10.27)에서는 정공 수송층과 발광층 사이에 정공 수송층 HOMO 에너지 준위와 발광층의 HOMO에너지 준위 사이의 HOMO준위를 갖는 발광 보조층을 형성시킨 유기 발광 소자에 관한 기술이 기재되어 있다.On the other hand, as a conventional technique related to the hole transporting layer, JP-A 10-1074193 (Oct. 2011, Oct. 14, 2011) discloses a method for producing a hole transporting layer comprising a compound having a gore structure in which at least one benzene ring is condensed in a carbazole structure Emitting device is disclosed in Japanese Patent Application Laid-Open No. 10-1455156 (Publication Date: Oct. 24, 2014, Oct. 27, 2014), an emission assistant having a HOMO energy level between a hole transport layer HOMO energy level and a light emission layer HOMO energy level is provided between a hole transport layer and a light emission layer Emitting layer having a layer formed thereon is disclosed.
그러나, 상기 선행문헌을 포함하는 종래기술에서 보다 효율적인 발광특성을 가지는 유기발광소자를 제조하기 위한 다양한 종류의 방법이 시도되었음에도 불구하고 아직도 저전압구동이 가능하며, 보다 개선된 발광효율과 장수명을 갖는 유기발광소자를 위한 전자수송층, 정공수송층 등으로 사용할 수 있는 재료 개발의 필요성은 지속적으로 요구되고 있는 실정이다. However, although various methods for manufacturing an organic light emitting device having more efficient light emitting characteristics have been attempted in the prior art including the above-mentioned prior arts, it is still possible to operate at a low voltage, and the organic light emitting device having improved luminous efficiency and long life There is a continuing need to develop a material that can be used as an electron transport layer and a hole transport layer for a light emitting device.
공개특허공보 제10-2012-0104204호(2012.09.20) Japanese Patent Application Laid-Open No. 10-2012-0104204 (2012.09.20)
일본공개특허공보 특개2010-168363 호(2010.08.05)Japanese Unexamined Patent Application Publication No. 2010-168363 (Aug. 05, 2010)
등록특허공보 제10-1074193호(공고일: 2011.10.14)Patent Registration No. 10-1074193 (Published on October 14, 2011)
등록특허공보 제10-1455156호(공고일: 2014.10.27)Patent Registration No. 10-1455156 (Publication date: Oct. 27, 2014)
따라서, 본 발명이 이루고자 하는 첫 번째 기술적 과제는 유기 발광 소자내 전자수송층 또는 정공수송층에 사용함으로써, 고효율, 저전압 및 장수명 특성을 가질 수 있는 특정한 구조의 유기 화합물을 제공하는 것이다.Accordingly, the first technical object of the present invention is to provide an organic compound having a specific structure capable of having high efficiency, low voltage, and long life characteristics by using it in an electron transporting layer or a hole transporting layer in an organic light emitting device.
또한 본 발명에 따른 두 번째 기술적 과제는 상기 유기 화합물을 전자수송층 또는 정공수송층에 포함하는 신규한 유기 발광 소자를 제공하는 것이다. A second object of the present invention is to provide a novel organic light emitting device including the organic compound in an electron transport layer or a hole transport layer.
본 발명은 상기 기술적 과제들을 달성하기 위하여, 하기 [화학식 A] 또는 [화학식 B]로 표시되는 유기 화합물을 제공한다. In order to achieve the above technical problems, the present invention provides an organic compound represented by the following formula (A) or (B).
[화학식 A] (A)
[화학식 B] [Chemical Formula B]
상기 [화학식 A] 및 [화학식 B]에서,In the above formulas (A) and (B)
상기 치환기 R1 내지 R14는 각각 동일하거나 상이하고, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 6 내지 50의 아릴기, 치환 또는 비치환된 탄소수 7 내지 50의 아릴알킬기, 치환 또는 비치환되고 이종원자로 O, N 또는 S를 갖는 탄소수 2 내지 50의 헤테로아릴기, 시아노기, 니트로기, 할로겐기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 6 내지 24의 아릴실릴기, 치환 또는 비치환된 게르마늄기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알루미늄기, 카르보닐기, 포스포릴기, 아미노기, 싸이올기, 히드록시기, 셀레늄기, 텔루륨기, 아미드기, 에테르기 및 에스테르기 중에서 선택되는 어느 하나이고,The substituents R 1 to R 14 are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, A substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C2 to C30 alkynyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C5 to C30 cycloalkenyl group, A substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkylthioxy group having 1 to 30 carbon atoms, a substituted or unsubstituted arylthioxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms A substituted or unsubstituted arylamine group having 6 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl group having 7 to 50 carbon atoms, , A substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms having O, N or S as a hetero atom, a cyano group, a nitro group, a halogen group, an alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 6 to 24 carbon atoms , A substituted or unsubstituted germanium group, a substituted or unsubstituted boron group, a substituted or unsubstituted aluminum group, a carbonyl group, a phosphoryl group, an amino group, a thiol group, a hydroxyl group, a selenium group, a tellurium group, An ester group,
각각 서로 인접하는 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S, O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있으며, And the carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be any one or more selected from N, S, and O, and the carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may form a monocyclic or polycyclic ring of alicyclic or aromatic, Which may be substituted by a heteroatom,
상기 [화학식 A] 에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A1 과 결합하는 단일결합이고In the above formula (A), one or two substituents of the substituents R 1 to R 12 are a single bond which binds to the above-mentioned Al
상기 [화학식 B]에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A2와 결합하는 단일결합이며, 상기 A2내 Ar2와 L2는 서로 연결되어 축합고리를 형성할 수 있고, 또한 Ar3과 L2는 서로 연결되어 축합고리를 형성할 수 있으며, In the above formula (B), one or two substituents of the substituents R 1 to R 12 are a single bond bonding to the A 2, Ar 2 and L 2 in the A 2 may be connected to each other to form a condensed ring, and Ar 3 and L 2 They may be connected to each other to form a condensed ring,
상기 연결기 L1 및 L2는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 1 내지 60의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 60의 시클로 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로시클로알킬렌기, 치환 또는 비치환된탄소수 6 내지 60의 아릴렌기 또는 치환 또는 비치환된탄소수 2 내지 60의 헤테로아릴렌기 중에서 선택되는 어느 하나이며;The linking groups L 1 and L 2 are the same or different and independently represent a substituted or unsubstituted alkylene group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenylene group having 2 to 60 carbon atoms, a substituted or unsubstituted C2- A substituted or unsubstituted C2-C60 alkynylene group, a substituted or unsubstituted C3-C60 cycloalkylene group, a substituted or unsubstituted C2-C60 heterocycloalkylene group, a substituted or unsubstituted C6-C60 arylene group, And an unsubstituted heteroarylene group having 2 to 60 carbon atoms;
n 및 m은 각각 동일하거나 상이하며, 서로 독립적으로 0 내지 3의 정수이되, 이들 각각이 2 이상인 경우에 각각의 연결기 L1 및 L2는 서로 동일하거나 상이하고,n and m are the same or different and independently of each other an integer of 0 to 3, and when each of these is 2 or more, each of the linking groups L1 and L2 is the same or different from each other,
상기 Ar1 내지 Ar3는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 6 내지 40의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 40의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기 중에서 선택되는 어느 하나이다. Each of Ar 1 to Ar 3 is the same or different and independently represents a substituted or unsubstituted aryl group having 6 to 40 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, a substituted or unsubstituted aryl group having 1 to 40 carbon atoms A substituted or unsubstituted alkyl group having 3 to 30 carbon atoms, and a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms.
또한 본 발명은 상기 두 번째 과제를 달성하기 위하여, 제1전극; 상기 제1전극에 대향된 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 개재된 유기층;을 포함하는 유기발광소자로서, 상기 유기층이 본 발명의 유기 화합물을 1종 이상 포함하는, 유기 발광 소자를 제공한다. According to another aspect of the present invention, there is provided a plasma display panel comprising: a first electrode; A second electrode facing the first electrode; And an organic layer interposed between the first electrode and the second electrode, wherein the organic layer comprises at least one organic compound of the present invention.
본 발명에 따른, [화학식 A] 또는 [화학식 B]로 표시되는 화합물을 전자수송층 또는 정공수송층에 포함하는 유기 발광 소자는 기존의 유기발광소자에 비하여 고효율, 저전압 및 장수명 특성을 가질 수 있다.The organic light emitting device comprising the compound represented by the formula (A) or (B) according to the present invention in the electron transporting layer or the hole transporting layer can have high efficiency, low voltage and long life characteristics as compared with the conventional organic light emitting device.
도 1은 본 발명의 일 구체예에 따른 유기 발광 소자의 개략도이다.1 is a schematic view of an organic light emitting device according to an embodiment of the present invention.
이하, 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 따른 유기 화합물은 하기 [화학식 A] 또는 [화학식 B]로 표시되는 구조를 가진다.The organic compound according to the present invention has a structure represented by the following formula (A) or (B).
[화학식 A] (A)
[화학식 B] [Chemical Formula B]
상기 [화학식 A] 및 [화학식 B]에서,In the above formulas (A) and (B)
상기 치환기 R1 내지 R14는 각각 동일하거나 상이하고, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 6 내지 50의 아릴기, 치환 또는 비치환된 탄소수 7 내지 50의 아릴알킬기, 치환 또는 비치환되고 이종원자로 O, N 또는 S를 갖는 탄소수 2 내지 50의 헤테로아릴기, 시아노기, 니트로기, 할로겐기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 6 내지 24의 아릴실릴기, 치환 또는 비치환된 게르마늄기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알루미늄기, 카르보닐기, 포스포릴기, 아미노기, 싸이올기, 히드록시기, 셀레늄기, 텔루륨기, 아미드기, 에테르기 및 에스테르기 중에서 선택되는 어느 하나이고,The substituents R 1 to R 14 are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, A substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C2 to C30 alkynyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C5 to C30 cycloalkenyl group, A substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkylthioxy group having 1 to 30 carbon atoms, a substituted or unsubstituted arylthioxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms A substituted or unsubstituted arylamine group having 6 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl group having 7 to 50 carbon atoms, , A substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms having O, N or S as a hetero atom, a cyano group, a nitro group, a halogen group, an alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 6 to 24 carbon atoms , A substituted or unsubstituted germanium group, a substituted or unsubstituted boron group, a substituted or unsubstituted aluminum group, a carbonyl group, a phosphoryl group, an amino group, a thiol group, a hydroxyl group, a selenium group, a tellurium group, An ester group,
각각 서로 인접하는 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S, O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있으며, And the carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be any one or more selected from N, S, and O, and the carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may form a monocyclic or polycyclic ring of alicyclic or aromatic, Which may be substituted by a heteroatom,
상기 [화학식 A] 에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A1 과 결합하는 단일결합이고In the above formula (A), one or two substituents of the substituents R 1 to R 12 are a single bond which binds to the above-mentioned Al
상기 [화학식 B]에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A2와 결합하는 단일결합이며, 상기 A2내 Ar2와 L2는 서로 연결되어 축합고리를 형성할 수 있고, 또한 Ar3 과 L2는 서로 연결되어 축합고리를 형성할 수 있으며, In the above formula (B), one or two substituents of the substituents R 1 to R 12 are a single bond bonding to the A 2, Ar 2 and L 2 in the A 2 may be connected to each other to form a condensed ring, and Ar 3 and L 2 They may be connected to each other to form a condensed ring,
상기 연결기 L1 및 L2는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 1 내지 60의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 60의 시클로 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로시클로알킬렌기, 치환 또는 비치환된탄소수 6 내지 60의 아릴렌기 또는 치환 또는 비치환된탄소수 2 내지 60의 헤테로아릴렌기 중에서 선택되는 어느 하나이며;The linking groups L 1 and L 2 are the same or different and independently represent a substituted or unsubstituted alkylene group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenylene group having 2 to 60 carbon atoms, a substituted or unsubstituted C2- A substituted or unsubstituted C2-C60 alkynylene group, a substituted or unsubstituted C3-C60 cycloalkylene group, a substituted or unsubstituted C2-C60 heterocycloalkylene group, a substituted or unsubstituted C6-C60 arylene group, And an unsubstituted heteroarylene group having 2 to 60 carbon atoms;
n 및 m은 각각 동일하거나 상이하며, 서로 독립적으로 0 내지 3의 정수이되, 이들 각각이 2 이상인 경우에 각각의 연결기 L1 및 L2는 서로 동일하거나 상이하고,n and m are the same or different and independently of each other an integer of 0 to 3, and when each of these is 2 or more, each of the linking groups L1 and L2 is the same or different from each other,
상기 Ar1 내지 Ar3는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 6 내지 40의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 40의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기 중에서 선택되는 어느 하나이고,Each of Ar 1 to Ar 3 is the same or different and independently represents a substituted or unsubstituted aryl group having 6 to 40 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, a substituted or unsubstituted aryl group having 1 to 40 carbon atoms A substituted or unsubstituted alkyl group having 3 to 30 carbon atoms, and a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms,
여기서, 상기‘치환 또는 비치환된’에서의 ‘치환’은 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 2 내지 24의 알케닐기, 탄소수 2 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 7 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내지 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 6 내지 24의 아릴실릴기, 탄소수 6 내지 24의 아릴옥시기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환되는 것을 의미한다. The 'substituted' in the 'substituted or unsubstituted' refers to a group selected from the group consisting of deuterium, a cyano group, a halogen group, a hydroxy group, a nitro group, an alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, An alkenyl group, an alkynyl group having 2 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 7 to 24 carbon atoms, a heteroaryl group having 2 to 24 carbon atoms, An alkyl group having 1 to 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, an alkylsilyl group having 1 to 24 carbon atoms, An aryloxy group, an aryloxy group, an arylsilyl group, and an aryloxy group having 6 to 24 carbon atoms.
한편, 본 발명에서의 상기 “치환 또는 비치환된 탄소수 1 내지 30의 알킬기”“치환 또는 비치환된 탄소수 6 내지 50의 아릴기”등에서의 상기 알킬기 또는 아릴기의 범위를 고려하여 보면, 상기 탄소수 1 내지 30의 알킬기 및 탄소수 6 내지 50의 아릴기의 탄소수의 범위는 각각 상기 치환기가 치환된 부분을 고려하지 않고 비치환된 것으로 보았을 때의 알킬 부분 또는 아릴 부분을 구성하는 전체 탄소수를 의미하는 것이다. 예컨대, 파라위치에 부틸기가 치환된 페닐기는 탄소수 4의 부틸기로 치환된 탄소수 6의 아릴기에 해당하는 것으로 보아야 한다. On the other hand, in consideration of the range of the alkyl or aryl group in the "substituted or unsubstituted C1-C30 alkyl group" or "substituted or unsubstituted C6-C50 aryl group" in the present invention, The carbon number of the alkyl group of 1 to 30 and the aryl group of the carbon number of 6 to 50 means the total number of carbon atoms constituting the alkyl moiety or the aryl moiety when it is considered that the substituent is not substituted without considering the substituted moiety . For example, a phenyl group substituted with a butyl group at the para position should be considered to correspond to an aryl group having 6 carbon atoms substituted with a butyl group having a carbon number of 4.
본 발명의 화합물에서 사용되는 치환기인 아릴기는 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 5 내지 7원, 바람직하게는 5 또는 6원을 포함하는 단일 또는 융합고리계를 포함하며, 또한 상기 아릴기에 치환기가 있는 경우 이웃하는 치환기와 서로 융합 (fused)되어 고리를 추가로 형성할 수 있다.The aryl group which is a substituent used in the compound of the present invention is an organic radical derived from an aromatic hydrocarbon by one hydrogen elimination and includes a single or fused ring system containing 5 to 7 atoms, preferably 5 or 6 atoms, When a substituent is present in the aryl group, the adjacent substituent may be fused with each other to form a ring.
상기 아릴기의 구체적인 예로는 페닐기, o-비페닐기, m-비페닐기, p-비페닐기, o-터페닐기, m-터페닐기, p-터페닐기, 나프틸기, 안트릴기, 페난트릴기, 피레닐기, 인데닐, 플루오레닐기, 테트라히드로나프틸기, 페릴렌일, 크라이세닐, 나프타세닐,플루오란텐일등과 같은 방향족 그룹을 들 수 있고, 상기 아릴기 중 하나 이상의 수소 원자는 중수소 원자, 할로겐 원자, 히드록시기, 니트로기, 시아노기, 실릴기, 아미노기 (-NH2, -NH(R), -N(R')(R''), R'과 R"은 서로 독립적으로 탄소수 1 내지 10의 알킬기이며, 이 경우 "알킬아미노기"라 함), 아미디노기, 히드라진기, 히드라존기, 카르복실기, 술폰산기, 인산기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 2 내지 24의 알케닐기, 탄소수 2 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 7 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기 또는 탄소수 2 내지 24의 헤테로아릴알킬기로 치환될 수 있다.Specific examples of the aryl group include a phenyl group, o-biphenyl group, m-biphenyl group, p-biphenyl group, o-terphenyl group, m- terphenyl group, p- terphenyl group, naphthyl group, anthryl group, An aromatic group such as a pyridyl group, an indenyl group, a fluorenyl group, a tetrahydronaphthyl group, a perylenyle, a crycenyl, a naphthacenyl, a fluoranthene and the like, and at least one hydrogen atom of the aryl group may be substituted with a deuterium atom, (-NH 2 , -NH (R), -N (R ') (R "), R' and R" each independently represent an alkyl group having 1 to 10 carbon atoms A hydrazine group, a hydrazone group, a carboxyl group, a sulfonic acid group, a phosphoric acid group, an alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, an alkyl group having 2 to 20 carbon atoms, An alkenyl group having 2 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, It may be substituted with a heteroaryl group of a small number of 6 to 24 aryl group, having 7 to 24 of the arylalkyl group, having 2 to 24 carbon atoms or heteroaryl group having 2 to 24.
본 발명의 화합물에서 사용되는 치환기인 헤테로아릴기는 N, O, P, Si, S, Ge, Se, Te 중에서 선택된 1, 2 또는 3개의 헤테로 원자를 포함하고, 나머지 고리 원자가 탄소인 탄소수 2 내지 24의 고리 방향족 시스템을 의미하며, 상기 고리들은 융합(fused)되어 고리를 형성할 수 있다. 그리고 상기 헤테로아릴기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.The heteroaryl group which is a substituent used in the compound of the present invention is a heteroaryl group having 2 to 24 carbon atoms in which the heteroaryl group includes 1,2 or 3 hetero atoms selected from N, O, P, Si, S, Ge, Refers to a ring aromatic system, which rings may be fused to form a ring. And at least one hydrogen atom of the heteroaryl group may be substituted with the same substituent as the aryl group.
또한 본 발명에서 상기 방향족 헤테로고리는 방향족 탄화수소 고리에서 방향족 탄소 중 하나이상이 N, O, P, Si, S, Ge, Se, Te 중에서 선택된 하나 이상의 헤테로 원자로 치환된 것을 의미한다. In the present invention, the aromatic heterocyclic ring means that at least one of aromatic carbons in the aromatic hydrocarbon ring is substituted with at least one hetero atom selected from N, O, P, Si, S, Ge, Se and Te.
본 발명에서 사용되는 치환기인 알킬기의 구체적인 예로는 메틸, 에틸, 프로필, 이소프로필, 이소부틸, sec-부틸, tert-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있고, 상기 알킬기 중 하나 이상의 수소 원자는 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the alkyl group as the substituent used in the present invention include methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, iso-amyl and hexyl. The hydrogen atom may be substituted with a substituent similar to that of the aryl group.
본 발명의 화합물에서 사용되는 치환기인 알콕시기의 구체적인 예로는 메톡시, 에톡시, 프로폭시, 이소부틸옥시, sec-부틸옥시, 펜틸옥시, iso-아밀옥시, 헥실옥시 등을 들 수 있고, 상기 알콕시기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the alkoxy group used as the substituent in the compound of the present invention include methoxy, ethoxy, propoxy, isobutyloxy, sec-butyloxy, pentyloxy, isoamyloxy, hexyloxy, At least one hydrogen atom in the alkoxy group may be substituted with the same substituent as in the case of the aryl group.
본 발명의 화합물에서 사용되는 치환기인 실릴기의 구체적인 예로는 트리메틸실릴, 트리에틸실릴, 트리페닐실릴, 트리메톡시실릴, 디메톡시페닐실릴, 디페닐메틸실릴, 디페닐비닐실릴, 메틸사이클로뷰틸실릴, 디메틸퓨릴실릴 등을 들 수 있고, 상기 실릴기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능 하다.Specific examples of the silyl group used as the substituent in the compound of the present invention include trimethylsilyl, triethylsilyl, triphenylsilyl, trimethoxysilyl, dimethoxyphenylsilyl, diphenylmethylsilyl, diphenylvinylsilyl, methylcyclobutylsilyl , And dimethylpurylsilyl. At least one hydrogen atom of the silyl group may be substituted with the same substituent as the aryl group.
본 발명에 따른 상기 [화학식 A] 또는 [화학식 B]로 표시되는 화합물의 특징을 보다 상세히 설명하면, ‘내지 R4를 포함하는 6원환 방향족 탄소고리 R13 및 R14를 포함하는 5원환 R5 내지 R12를 포함하는 탄소수 14의 방향족 탄소고리(페난트렌 골격)’가 서로 축합된 형태의 구조를 가지며, 이들 축합고리내 치환기 R1 내지 R21중 하나 또는 두 개의 치환기가 상기 A1 또는 A2와 결합하는 단일 결합인 것을 특징으로 한다.More specifically, the compounds represented by the above formula (A) or (B) according to the present invention will be described in more detail. They include 5-membered rings R5 to R12 including 6-membered ring aromatic rings R13 and R14 (Phenanthrene skeleton) 'having a carbon number of 14 is condensed with each other, and one or two substituents of the substituents R 1 to R 21 in these condensed rings are single bonds bonded to the A 1 or A 2. .
일 실시예로서, 상기 치환기 Ar1 내지 Ar3는 각각 동일하거나 상이하고, 서로 독립적으로 비치환된 탄소수 6 내지 30의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기 중에서 선택되는 어느 하나일 수 있다.In one embodiment, the substituents Ar1 to Ar3 are the same or different and each independently selected from the group consisting of unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 2 to 30 carbon atoms, .
또한 상기 치환기 R13 및 R14는 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 20의 알킬기, 또는 치환 또는 비치환된 탄소수 6 내지 20의 아릴기일 수 있다.The substituents R13 and R14 may be the same or different and are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms.
또한 상기 [화학식 A]내 Ar1은 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기일 수 있으며, 이경우에 상기 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기는 하기 구조식 A 내지 구조식 Q에서 선택되는 어느 하나일 수 있다.The substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms may be a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, and the substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms is selected from the following structural formulas A to Q It can be either.
[구조식 A] [구조식 B] [구조식 C] [Structural Formula A] [Structural formula B] [Structural formula C]
[구조식 D] [구조식 E] [구조식 F] [Structural formula D] [Structural formula E] [Structural formula F]
[구조식 G] [구조식 H] [구조식 I][Structural formula G] [Structural formula H] [Structural formula I]
[구조식 J] [구조식 K] [구조식 L][Structural formula J] [Structural formula K] [Structural formula L]
[구조식 M] [구조식 N] [구조식 O][Structural formula M] [Structural formula N] [Structural formula O]
[구조식 P] [구조식 Q][Structural formula P] [Structural formula Q]
상기 구조식 A 내지 구조식 Q내 치환기 R은 앞서 정의된 R1 내지 R14와 동일하며,Substituent R in the structural formulas A to Q is the same as R1 to R14 defined above,
상기 k는 1 내지 7의 정수이되, k가 2 이상인 경우에 각각의 치환기 R은 동일하거나 상이하며,K is an integer of 1 to 7, and when k is 2 or more, each substituent R is the same or different,
k가 2 이상인 경우에 각각의 치환기 R은 서로 인접하는 치환기 R과 결합되어 포화 또는 불포화 고리를 형성할 수 있다. When k is 2 or more, each substituent R may be bonded to adjacent substituent R to form a saturated or unsaturated ring.
한편, 상기 화학식 B에서 Ar2 및 Ar3는 각각 동일하거나 상이하며, 서로 독립적으로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기일 수 있다.In formula (B), Ar2 and Ar3 may be the same or different and independently of each other, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 발명에 따른 일 실시예로서, 상기 화학식 A 및 화학식 B에서, 상기 치환기 R1 내지 R4중 하나가 A1 또는 A2와 결합하는 단일결합이거나, 또는 상기 치환기 R5 내지 R12중 하나가 A1 또는 A2와 결합하는 단일결합일 수 있다.In one embodiment according to the present invention, in the above formula (A) and formula (B), one of the substituents R 1 to R 4 is a single bond bonding to A 1 or A 2, or one of the substituents R 5 to R 12 is bonded to A 1 or A 2 May be a single bond.
본 발명에 따른 일 실시예로서, 상기 치환기 R1 내지 R12 중 상기 A1 또는 A2와 연결되지 않는 치환기는 수소 또는 중수소 일 수 있다. In an embodiment according to the present invention, the substituent which is not connected to A1 or A2 among the substituents R1 to R12 may be hydrogen or deuterium.
본 발명에 따른 일 실시예로서, 상기 연결기 L1 및 L2는 서로 동일하거나 상이하며, 각각 독립적으로 단일결합이거나, 아래 구조식 1 내지 구조식 9 중에서 선택되는 어느 하나일 수 있다.In one embodiment of the present invention, the linking groups L 1 and L 2 may be the same or different from each other, and each may be a single bond or any one selected from the following structural formulas 1 to 9.
[구조식 1] [구조식 2] [구조식 3] [구조식 4][Structural Formula 1] [Structural Formula 2] [Structural Formula 3] [Structural Formula 4]
[구조식 5] [구조식 6] [구조식 7][Structural formula 5] [Structural formula 6] [Structural formula 7]
[구조식 8] [구조식 9][Structural formula 8] [Structural formula 9]
상기 구조식1 내지 구조식 9에서 방향족 고리의 탄소자리는 수소 또는 중수소가 결합된다. In the structural formulas 1 to 9, the carbon of the aromatic ring is bonded to hydrogen or deuterium.
한편, 본 발명의 상기 [화학식 A]로 표시되는 유기화합물은, 치환기 R1 내지 R12 중 하나의 치환기만이 상기 A1 과 결합하는 단일결합인 화합물일 수 있다On the other hand, the organic compound represented by the above-mentioned formula (A) of the present invention may be a compound in which only one substituent of the substituent groups R 1 to R 12 is a single bond to the above-mentioned Al
본 발명에 따른 상기 [화학식 A] 또는 [화학식 B]로 표시되는 유기 화합물의 구체적인 예로서는 하기 [화합물 1] 내지 [화합물 144]로 표시되는 군으로부터 선택된 어느 하나로 표시되는 화합물일 수 있으나, 이에 제한되지 않는다.Specific examples of the organic compound represented by the above formula (A) or (B) according to the present invention may be a compound represented by any one selected from the following [compounds 1] to [144] Do not.
[화합물 1] [화합물 2] [화합물 3] [화합물 4][Compound 1] [Compound 2] [Compound 3] [Compound 4]
[화합물 5] [화합물 6] [화합물 7] [화합물 8][Compound 5] [Compound 6] [Compound 7] [Compound 8]
[화합물 9] [화합물 10] [화합물 11] [화합물 12][Compound 9] [Compound 10] [Compound 11] [Compound 12]
[화합물 13] [화합물 14] [화합물 15] [화합물 16][Compound 13] [Compound 14] [Compound 15] [Compound 16]
[화합물 17] [화합물 18] [화합물 19] [화합물 20][Compound 17] [Compound 18] [Compound 19] [Compound 20]
[화합물 21] [화합물 22] [화합물 23] [화합물 24][Compound 21] [Compound 22] [Compound 23] [Compound 24]
[화합물 25] [화합물 26] [화합물 27] [화합물 28][Compound 25] [Compound 26] [Compound 27] [Compound 28]
[화합물 29] [화합물 30] [화합물 31] [화합물 32][Compound 29] [Compound 30] [Compound 31] [Compound 32]
[화합물 33] [화합물 34] [화합물 35] [화합물 36][Compound 33] [Compound 34] [Compound 35] [Compound 36]
[화합물 37] [화합물 38] [화합물 39] [화합물 40][Compound 37] [Compound 38] [Compound 39] [Compound 40]
[화합물 41] [화합물 42] [화합물 43] [화합물 44][Compound 41] [Compound 42] [Compound 43] [Compound 44]
[화합물 45] [화합물 46] [화합물 47] [화합물 48][Compound 45] [Compound 46] [Compound 47] [Compound 48]
[화합물 49] [화합물 50] [화합물 51] [화합물 52][Compound 49] [Compound 50] [Compound 51] [Compound 52]
[화합물 53] [화합물 54] [화합물 55] [화합물 56][Compound 53] [Compound 54] [Compound 55] [Compound 56]
[화합물 57] [화합물 58] [화합물 59] [화합물 60][Compound 57] [Compound 58] [Compound 59] [Compound 60]
[화합물 61] [화합물 62] [화합물 63] [화합물 64][Compound 61] [Compound 62] [Compound 63] [Compound 64]
[화합물 65] [화합물 66] [화합물 67] [화합물 68][Compound 65] [Compound 66] [Compound 67] [Compound 68]
[화합물 69] [화합물 70] [화합물 71] [화합물 72][Compound 69] [Compound 70] [Compound 71] [Compound 72]
[화합물 73] [화합물 74] [화합물 75] [화합물 76][Compound 73] [Compound 74] [Compound 75] [Compound 76]
[화합물 77] [화합물 78] [화합물 79] [화합물 80][Compound 77] [Compound 78] [Compound 79] [Compound 80]
[화합물 81] [화합물 82] [화합물 83] [화합물 84][Compound 81] [Compound 82] [Compound 83] [Compound 84]
[화합물 85] [화합물 86] [화합물 87] [화합물 88][Compound 85] [Compound 86] [Compound 87] [Compound 88]
[화합물 89] [화합물 90] [화합물 91] [화합물 92][Compound 89] [Compound 90] [Compound 91] [Compound 92]
[화합물 93] [화합물 94] [화합물 95] [화합물 96][Compound 93] [Compound 94] [Compound 95] [Compound 96]
[화합물 97] [화합물 98] [화합물 99] [화합물 100][Compound 97] [Compound 98] [Compound 99] [Compound 100]
[화합물 101] [화합물 102] [화합물 103] [화합물 104][Compound 101] [Compound 102] [Compound 103] [Compound 104]
[화합물 105] [화합물 106] [화합물 107] [화합물 108][Compound 105] [Compound 106] [Compound 107] [Compound 108]
[화합물 109] [화합물 110] [화합물 111] [화합물 112][Compound 109] [Compound 110] [Compound 111] [Compound 112]
[화합물 113] [화합물 114] [화합물 115] [화합물 116][Compound 113] [Compound 114] [Compound 115] [Compound 116]
[화합물 117] [화합물 118] [화합물 119] [화합물 120][Compound 117] [Compound 118] [Compound 119] [Compound 120]
[화합물 121] [화합물 122] [화합물 123] [화합물 124][Compound 121] [Compound 122] [Compound 123] [Compound 124]
[화합물 125] [화합물 126] [화합물 127] [화합물 128][Compound 125] [Compound 126] [Compound 127] [Compound 128]
[화합물 129] [화합물 130] [화합물 131] [화합물 132][Compound 129] [Compound 130] [Compound 131] [Compound 132]
[화합물 133] [화합물 134] [화합물 135] [화합물 136][Compound 133] [Compound 134] [Compound 135] [Compound 136]
[화합물 137] [화합물 138] [화합물 139] [화합물 140][Compound 137] [Compound 138] [Compound 139] [Compound 140]
[화합물 141] [화합물 142] [화합물 143] [화합물 144][Compound 141] [Compound 142] [Compound 143] [Compound 144]
또한, 본 발명은 제1전극; 상기 제1전극에 대향된 제2전극; 및 상기 제1전극과 상기 제2전극 사이에 개재되는 유기층;을 포함하는 유기발광소자로서, 상기 유기층이 앞서 기재된, 본 발명에 따른 유기 화합물을 포함하는 것을 특징으로 하는 유기발광소자를 제공한다. The present invention also provides a plasma display panel comprising: a first electrode; A second electrode facing the first electrode; And an organic layer interposed between the first electrode and the second electrode, wherein the organic layer includes the organic compound according to the present invention described above.
이때, 본 발명에서 “유기층이) 유기 화합물을 1종 이상 포함한다”란, “유기층이) 본 발명의 범주에 속하는 1종의 유기 화합물 또는 상기 유기 화합물의 범주에 속하는 서로 다른 2종 이상의 화합물을 포함할 수 있다”로 해석될 수 있다.Herein, " an organic layer includes at least one organic compound " in the present invention means that one organic compound belonging to the category of the present invention or two or more different compounds belonging to the category of the organic compound May be included.
이때, 상기 본 발명의 유기 화합물이 포함된 유기층은 정공 주입층, 정공 수송층, 정공 주입 기능 및 정공 수송 기능을 동시에 갖는 기능층, 발광층, 전자 수송층, 및 전자 주입층 중 적어도 하나를 포함할 수 있다.At this time, the organic layer containing the organic compound of the present invention may include at least one of a hole injection layer, a hole transport layer, a functional layer having both a hole injection function and a hole transport function, a light emitting layer, an electron transport layer, and an electron injection layer .
또한, 본 발명의 유기화합물은 정공 수송층 용도로 사용하거나, 전자 수송층 용도로 사용할 수 있다.Further, the organic compound of the present invention can be used for a hole transporting layer or for an electron transporting layer.
본 발명에 따른 상기 정공수송층의 재료로는 본 발명의 상기 화학식 A 또는 화학식 B로 표시되는 유기 화합물이 사용될 수 있다. 또한 상기 화학식 A 또는 화학식 B로 표시되는 유기 화합물이외에 다른 화합물들이 추가적으로 포함되어 사용될 수 있으며, 통상적으로 이온화 포텐셜이 작은 전자공여성 분자가 사용가능하며, 주로 트리페닐아민을 기본 골격으로 하는 디아민, 트리아민 또는 테트라아민 유도체가 많이 사용되고 있고, 예를 들어, N,N'-비스(3-메틸페닐)-N,N'-디페닐-[1,1-비페닐]-4,4'-디아민(TPD) 또는 N,N'-디(나프탈렌-1-일)-N,N'-디페닐벤지딘 (a-NPD) 등을 추가적으로 사용할 수 있다. As the material of the hole transporting layer according to the present invention, organic compounds represented by the above formula (A) or (B) can be used. In addition, compounds other than the organic compound represented by the above-mentioned formula (A) or (B) can be additionally used, and electron-donating molecules having a low ionization potential can be used, and diamine, triamine Or tetraamine derivatives are widely used, and for example, N, N'-bis (3-methylphenyl) -N, N'- diphenyl- [1,1-biphenyl] -4,4'-diamine ), N, N'-di (naphthalene-1-yl) -N, N'-diphenylbenzidine (a-NPD)
상기 정공수송층의 하부에는 정공주입층(HIL, Hole Injecting Layer)을 추가적으로 더 적층할 수 있는데, 상기 정공주입층 재료 역시 본 발명의 상기 화학식 A 또는 화학식 B로 표시되는 유기 화합물을 사용할 수 있고, 본 발명의 상기 화학식 A 또는 화학식 B로 표시되는 유기 화합물이 사용되지 않는 경우에는 당업계에서 통상적으로 사용되는 정공 주입층이 사용될 수 있다. A hole injection layer (HIL) may be additionally formed on the lower part of the hole transport layer. The hole injection layer material may be an organic compound represented by the formula (A) or (B) In the case where the organic compound represented by the above formula (A) or (B) is not used, a hole injection layer commonly used in the art can be used.
이러한 통상적으로 사용되는 정공 주입층은, 예를 들어 CuPc(copperphthalocyanine) 또는 스타버스트형 아민류인 TCTA(4,4',4"-tri(N-carbazolyl)triphenyl-amine), m-MTDATA(4,4',4"-tris-(3-methylphenylphenyl amino)triphenylamine) 등이 사용될 수 있다.Such conventionally used hole injection layers include, for example, copper phthalocyanine (CuPc) or starburst type amine TCTA (4,4 ', 4 "-tri (N-carbazolyl) triphenylamine), m- 4 ', 4 "-tris- (3-methylphenylphenylamino) triphenylamine) and the like can be used.
또한, 본 발명에서의 유기발광소자내 상기 발광층은 호스트와 도판트로 이루어질 수 있으며, 이 경우에 상기 발광층에 사용되는 호스트는 아래 화학식 H로 표시되는 1종 이상의 화합물을 포함할 수 있으나 이에 제한되지 않는다.In addition, the light emitting layer in the organic light emitting device of the present invention may be composed of a host and a dopant. In this case, the host used in the light emitting layer may include at least one compound represented by the following formula (H) .
[화학식 H][Formula H] <
상기 [화학식 H]에서, In the above formula (H)
상기 X1내지 X10는 각각 동일하거나 상이하고, 서로 독립적으로 수소 원자, 중수소 원자, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 3 내지30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환되고 이종 원자로 O, N 또는 S를 갖는 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 실리콘기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 실란기, 카르보닐기, 포스포릴기, 아미노기, 니트릴기, 히드록시기, 니트로기, 할로겐기, 아미드기 및 에스테르기로 이루어진 군에서 선택되는 어느 하나이며, 서로 인접하는 기는 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성할 수 있다.X 1 to X 10 are the same or different from each other and each independently represent a hydrogen atom, a deuterium atom, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, A substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted cycloalkenyl group having 5 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 30 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms , A substituted or unsubstituted alkylthio group having 1 to 30 carbon atoms, a substituted or unsubstituted arylthioxy group having 5 to 30 carbon atoms, a substituted or unsubstituted alkylamine group having 1 to 30 carbon atoms, a substituted or unsubstituted 5 A substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 50 carbon atoms having O, N or S, a substituted or unsubstituted hetero atom, a substituted Is a group selected from the group consisting of an unsubstituted silicon group, a substituted or unsubstituted boron group, a substituted or unsubstituted silane group, a carbonyl group, a phosphoryl group, an amino group, a nitrile group, a hydroxyl group, a nitro group, a halogen group, an amide group and an ester group And the groups adjacent to each other may form a condensed ring of an aliphatic, aromatic, aliphatic hetero or aromatic hetero.
보다 구체적으로, 상기 호스트는 하기 [화합물 201] 내지 [화합물 396]으로 표시되는 군으로부터 선택되는 어느 하나로 표시될 수 있으나, 이에 한정된 것은 아니다.More specifically, the host may be represented by any one selected from the group consisting of [compounds 201] to [396], but is not limited thereto.
[화합물 201] [화합물 202] [화합물 203] [화합물 204][Compound 201] [Compound 202] [Compound 203] [Compound 204]
[화합물 205] [화합물 206] [화합물 207] [화합물 208][Compound 205] [Compound 206] [Compound 207] [Compound 208]
[화합물209] [화합물210] [화합물211] [화합물212][Compound 209] [Compound 210] [Compound 211] [Compound 212]
[화합물213] [화합물214] [화합물215] [화합물216][Compound 213] [Compound 214] [Compound 215] [Compound 216]
[화합물217] [화합물218] [화합물219] [화합물220][Compound 217] [Compound 218] [Compound 219] [Compound 220]
[화합물221] [화합물222] [화합물223] [화합물224][Compound 221] [Compound 222] [Compound 223] [Compound 224]
[화합물225] [화합물226] [화합물227] [화합물228][Compound 225] [Compound 226] [Compound 227] [Compound 228]
[화합물229] [화합물230] [화합물231] [화합물232][Compound 229] [Compound 230] [Compound 231] [Compound 232]
[화합물233] [화합물234] [화합물235] [화합물236][Compound 233] [Compound 234] [Compound 235] [Compound 236]
[화합물237] [화합물238] [화합물239] [화합물240][Compound 237] [Compound 238] [Compound 239] [Compound 240]
[화합물241] [화합물242] [화합물243] [화합물244][Compound 241] [Compound 242] [Compound 243] [Compound 244]
[화합물245] [화합물246] [화합물247] [화합물248][Compound 245] [Compound 246] [Compound 247] [Compound 248]
[화합물249] [화합물250] [화합물251] [화합물252][Compound 249] [Compound 250] [Compound 251] [Compound 252]
[화합물253] [화합물254] [화합물255] [화합물256][Compound 253] [Compound 254] [Compound 255] [Compound 256]
[화합물257] [화합물258] [화합물259] [화합물260][Compound 257] [Compound 258] [Compound 259] [Compound 260]
[화합물261] [화합물262] [화합물263] [화합물264][Compound 261] [Compound 262] [Compound 263] [Compound 264]
[화합물265] [화합물266] [화합물267] [화합물268][Compound 265] [Compound 266] [Compound 267] [Compound 268]
[화합물269] [화합물270] [화합물271] [화합물272][Compound 269] [Compound 270] [Compound 271] [Compound 272]
[화합물273] [화합물274] [화합물275] [화합물276][Compound 273] [Compound 274] [Compound 275] [Compound 276]
[화합물277] [화합물278] [화합물279] [화합물280][Compound 277] [Compound 278] [Compound 279] [Compound 280]
[화합물281] [화합물282] [화합물283] [화합물284][Compound 281] [Compound 282] [Compound 283] [Compound 284]
[화합물285] [화합물286] [화합물287] [화합물288][Compound 285] [Compound 286] [Compound 287] [Compound 288]
[화합물289] [화합물290] [화합물291] [화합물292][Compound 289] [Compound 290] [Compound 291] [Compound 292]
[화합물293] [화합물294] [화합물295] [화합물296][Compound 293] [Compound 294] [Compound 295] [Compound 296]
[화합물297] [화합물298] [화합물299] [화합물300][Compound 297] [Compound 298] [Compound 299] [Compound 300]
[화합물301] [화합물302] [화합물303] [화합물304][Compound 301] [Compound 302] [Compound 303] [Compound 304]
[화합물305] [화합물306] [화합물307] [화합물308][Compound 305] [Compound 306] [Compound 307] [Compound 308]
[화합물309] [화합물310] [화합물311] [화합물312][Compound 309] [Compound 310] [Compound 311] [Compound 312]
[화합물313] [화합물314] [화합물315] [화합물316][Compound 313] [Compound 314] [Compound 315] [Compound 316]
[화합물317] [화합물318] [화합물319] [화합물320][Compound 317] [Compound 318] [Compound 319] [Compound 320]
[화합물321] [화합물322] [화합물323] [화합물324][Compound 321] [Compound 322] [Compound 323] [Compound 324]
[화합물325] [화합물326] [화합물327] [화합물328][Compound 325] [Compound 326] [Compound 327] [Compound 328]
[화합물329] [화합물330] [화합물331] [화합물332][Compound 329] [Compound 330] [Compound 331] [Compound 332]
[화합물333] [화합물334] [화합물335] [화합물336][Compound 333] [Compound 334] [Compound 335] [Compound 336]
[화합물337] [화합물338] [화합물339] [화합물340][Compound 337] [Compound 338] [Compound 339] [Compound 340]
[화합물341] [화합물342] [화합물343] [화합물344][Compound 341] [Compound 342] [Compound 343] [Compound 344]
[화합물345] [화합물346] [화합물347] [화합물348][Compound 345] [Compound 346] [Compound 347] [Compound 348]
[화합물349] [화합물350] [화합물351] [화합물352][Compound 349] [Compound 350] [Compound 351] [Compound 352]
[화합물353] [화합물354] [화합물355] [화합물356][Compound 353] [Compound 354] [Compound 355] [Compound 356]
[화합물357] [화합물358] [화합물359] [화합물360][Compound 357] [Compound 358] [Compound 359] [Compound 360]
[화합물361] [화합물362] [화합물363] [화합물364][Compound 361] [Compound 362] [Compound 363] [Compound 364]
[화합물365] [화합물366] [화합물367] [화합물368][Compound 365] [Compound 366] [Compound 367] [Compound 368]
[화합물369] [화합물370] [화합물371] [화합물372][Compound 369] [Compound 370] [Compound 371] [Compound 372]
[화합물373] [화합물374] [화합물375] [화합물376][Compound 373] [Compound 374] [Compound 375] [Compound 376]
[화합물377] [화합물378] [화합물379] [화합물380][Compound 377] [Compound 378] [Compound 379] [Compound 380]
[화합물381] [화합물382] [화합물383] [화합물384][Compound 381] [Compound 382] [Compound 383] [Compound 384]
[화합물385] [화합물386] [화합물387] [화합물388][Compound 385] [Compound 386] [Compound 387] [Compound 388]
[화합물389] [화합물390] [화합물391] [화합물392][Compound 389] [Compound 390] [Compound 391] [Compound 392]
[화합물393] [화합물394] [화합물395] [화합물396][Compound 393] [Compound 394] [Compound 395] [Compound 396]
한편, 본 발명의 유기발광소자내 발광층에 사용되는 도판트는 하기 [화학식 1] 또는 [화학식 2]로 표시되는 화합물일 수 있고, 이외에도 다양한 공지의 도판트 물질이 사용될 수 있다. Meanwhile, the dopant used in the light emitting layer in the organic light emitting device of the present invention may be a compound represented by the following formula (1) or (2), and various known dopant materials may be used.
[화학식 1] [화학식 2] [Chemical Formula 1] < EMI ID =
상기 [화학식 1]와 [화학식 2] 중,Among the above-mentioned formulas (1) and (2)
A는 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환되고 이종 원자로 O, N 또는 S를 갖는 탄소수 3 내지 50의 헤테로아릴기, 치환되거나 치환되지 않은 탄소수 6 내지 60의 아릴렌기, 치환 또는 비치환되고 이종 원자로 O, N 또는 S를 갖는 탄소수 3 내지 50의 헤테로아릴렌기 중에서 선택되는 어느 하나일 수 있다.A is a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 50 carbon atoms having O, N or S as a hetero atom, an optionally substituted arylene group having 6 to 60 carbon atoms , A substituted or unsubstituted heteroarylene group having 3 to 50 carbon atoms having a hetero atom O, N or S, and the like.
보다 구체적으로, A는 치환되거나 치환되지 않은 탄소수 6 내지 60의 아릴렌기, 또는 단일결합이고, 바람직하게는 안트라센, 파이렌, 페난트렌, 인데노페난트렌, 크라이센, 나프타센, 피센, 트리페닐렌, 페릴렌, 펜타센 중 어느 하나일 수 있고, 더욱 상세하게는, 상기 A는 하기 화학식 A1 내지 화학식A10중 어느 하나로 표시되는 치환기일 수 있다. More specifically, A is a substituted or unsubstituted arylene group having 6 to 60 carbon atoms or a single bond, preferably an anthracene, pyrene, phenanthrene, indenophenanthrene, klysene, naphthacene, Perylene, pentacene, and more particularly, the A may be a substituent represented by any one of the following formulas (A1) to (A10).
[화학식A1] [화학식A2] [화학식A3] [Formula A1] [Formula A2] [Formula A3]
[화학식A4] [화학식A5] [화학식A6][Chemical Formula A4] [Chemical Formula A5] [Chemical Formula A6]
[화학식A7] [화학식A8] [화학식A9] [Chemical formula A7] [Chemical formula A8] [Chemical formula A9]
[화학식A10](A10)
여기서 상기 [화학식 A3]의 Z1 내지 Z2는 수소, 중수소원자, 치환 또는 비치환된 탄소수 1 내지 60의 알킬기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐기, 치환 또는 비치환된 탄소수 1 내지 60의 알콕시기, 치환 또는 비치환된 탄소수 1 내지 60의 알킬티오기(alkylthio), 치환 또는 비치환된 탄소수 3 내지 60의 시클로알킬기, 치환 또는 비치환된 탄소수 6 내지 60의 아릴기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴옥시기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴싸이오기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 60의 (알킬)아미노기, 디(치환 또는 비치환된 탄소수 1 내지 60의 알킬)아미노기, 또는 (치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기, 디(치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기로 이루어진 군으로부터 1종 이상 선택되고, Z1 내지 Z2 각각은 서로 동일하거나 상이하며, 서로 인접하는 기와 축합 고리를 형성할 수 있다.Wherein Z 1 to Z 2 in the formula [A3] are each independently selected from the group consisting of hydrogen, a deuterium atom, a substituted or unsubstituted alkyl group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 60 carbon atoms, A substituted or unsubstituted alkoxy group having 1 to 60 carbon atoms, a substituted or unsubstituted alkylthio group having 1 to 60 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 60 carbon atoms, a substituted Or an unsubstituted or substituted aryl group having 6 to 60 carbon atoms, a substituted or unsubstituted aryloxy group having 5 to 60 carbon atoms, a substituted or unsubstituted arylthio group having 5 to 60 carbon atoms, a substituted or unsubstituted aryl group having 2 to 60 carbon atoms (Substituted or unsubstituted C1-C60 alkyl) amino group, or a substituted or unsubstituted C6-C60 aryl) amino group, a substituted or unsubstituted C1-C60 alkylamino group, , (Substituted or unsubstituted aryl group having 6 to 60 carbon atoms) amino group, and Z 1 to Z 2 are the same or different from each other and can form a condensed ring with adjacent groups.
또한 상기 [화학식 1] 중, In the above formula (1)
상기 X1 및 X2는 각각 독립적으로 치환되거나 치환되지 않은 탄소수 6 내지 30의 아릴렌기이거나 단일결합이고, X1과 X2는 서로 결합될 수 있고, X 1 and X 2 are each independently a substituted or unsubstituted arylene group having 6 to 30 carbon atoms or a single bond, X 1 and X 2 may be bonded to each other,
상기 Y1 및 Y2는 각각 독립적으로 치환되거나 치환되지 않은 탄소수 6 내지 24의 아릴기, 치환 또는 비치환된 탄소수 2 내지 24의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 24의 알킬기, 치환 또는 비치환된 탄소수 1 내지 24의 헤테로알킬기, 치환 또는 비치환된 탄소수 3 내지 24의 사이클로알킬기, 치환 또는 비치환된 탄소수 1 내지 24의 알콕시기, 시아노기, 할로겐기, 치환 또는 비치환된 탄소수 6 내지 24의 아릴옥시기, 치환 또는 비치환 된 탄소수 1 내지 40의 알킬실릴기, 치환 또는 비치환 된 탄소수 6 내지 30의 아릴실릴기, 게르마늄, 인, 보론, 중수소 및 수소로 이루어진 군으로부터 1종 이상 선택되고, Y1내지 Y2 각각은 서로 동일하거나 상이하며, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성할 수 있으며.Y 1 and Y 2 are each independently a substituted or unsubstituted aryl group having 6 to 24 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 24 carbon atoms, a substituted or unsubstituted alkyl group having 1 to 24 carbon atoms, a substituted Or a substituted or unsubstituted C1 to C24 heteroalkyl group, a substituted or unsubstituted C3 to C24 cycloalkyl group, a substituted or unsubstituted C1 to C24 alkoxy group, a cyano group, a halogen group, a substituted or unsubstituted carbon number A substituted or unsubstituted alkyl group having 1 to 40 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 30 carbon atoms, germanium, phosphorus, boron, deuterium, and hydrogen. more selected species and, Y 1 to Y 2 each are the same or different each other, may form a fused ring group of the aliphatic, aromatic, aliphatic hetero, or aromatic heterocyclic group which are adjacent to each other It was.
상기 l, m 은 각각 1 내지 20의 정수이고, n은 1 내지 4의 정수이다.Each of l and m is an integer of 1 to 20, and n is an integer of 1 to 4.
또한 상기 [화학식 2] 중, In the above formula (2)
Cy는 치환 또는 비치환된 탄소수 3 내지 8의 시클로알킬이고, b은 1 내지 4 의 정수이되, b이 2 이상인 경우 각각의 시클로알칸은 융합된 형태일 수 있고, 또한, 이에 치환된 수소는 각각 중수소 또는 알킬로 치환될 수 있으며, 서로 동일하거나 상이할 수 있다. C y is a substituted or unsubstituted cycloalkyl having 3 to 8 carbon atoms, b is an integer of 1 to 4, and when b is 2 or more, each cycloalkane may be in a fused form, Each of which may be substituted with deuterium or alkyl, and may be the same as or different from each other.
또한 상기 B 는 단일 결합 또는 [C(R5)(R6)]p이고, 상기 p는 1 내지 3의 정수이되, p가 2 이상인 경우 2 이상의 R5 및 R6은 서로 동일하거나 상이하고; In addition, It is a single bond or [C (R 5) (R 6)] p, wherein p is an integer and are from 1 to 3, p is 2 or more two or more of R 5 and R 6 are the same or different from each other;
상기 R1, R2, R3, R5 및 R6은 서로 독립적으로, 수소, 중수소, 할로겐 원자, 히드록실기, 시아노기, 니트로기, 아미노기, 아미디노기, 히드라진, 히드라존, 카르복실기나 이의 염, 술폰산기나 이의 염, 인산이나 이의 염, 치환 또는 비치환된 탄소수 1 내지 60의 알킬기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐기, 치환 또는 비치환된 탄소수 1 내지 60의 알콕시기, 치환 또는 비치환된 탄소수 1 내지 60의 알킬티오기(alkylthio), 치환 또는 비치환된 탄소수 3 내지 60의 시클로알킬기, 치환 또는 비치환된 탄소수 6 내지 60의 아릴기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴옥시기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴싸이오기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 60의 (알킬)아미노기, 디(치환 또는 비치환된 탄소수 1 내지 60의 알킬)아미노기, 또는 (치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기, 디(치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기, 치환 또는 비치환 된 탄소수 1 내지 40의 알킬실릴기, 치환 또는 비치환 된 탄소수 6 내지 30의 아릴실릴기, 게르마늄, 인, 보론 중에서 선택될 수 있으며, Wherein R 1, R 2, R 3 , R 5 and R 6 are, each independently, hydrogen, deuterium, a halogen atom, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, hydrazine, hydrazone, a carboxyl group or A substituted or unsubstituted alkyl group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 60 carbon atoms, a substituted or unsubstituted alkynyl group having 2 to 60 carbon atoms , A substituted or unsubstituted alkoxy group having 1 to 60 carbon atoms, a substituted or unsubstituted alkylthio group having 1 to 60 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 60 carbon atoms, a substituted or unsubstituted carbon number A substituted or unsubstituted aryloxy group having 6 to 60 carbon atoms, a substituted or unsubstituted aryloxy group having 5 to 60 carbon atoms, a substituted or unsubstituted arylthio group having 5 to 60 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms, Or beach (Substituted or unsubstituted alkyl group having 1 to 60 carbon atoms), a di (substituted or unsubstituted alkyl group having 1 to 60 carbon atoms) amino group, a substituted or unsubstituted amino group having 6 to 60 carbon atoms, An aryl group having 6 to 60 carbon atoms, a substituted or unsubstituted alkylsilyl group having 1 to 40 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 30 carbon atoms, germanium, phosphorus, boron,
a는 1 내지 4의 정수이되, a가 2 이상인 경우 2 이상의 R3는 서로 동일하거나 상이하고, R3 이 복수인 경우, 각각의 R3은 융합된 형태일 수 있고, n은 1 내지 4의 정수이다.a is an integer of 1 to 4, and when a is 2 or more, R 3 of 2 or more are the same or different, and when R 3 is plural, each R 3 may be in fused form, and n is 1 to 4 It is an integer.
또한, 상기 [화학식 1]과 [화학식 2]의 A에 결합되는 아민기는 하기 [치환기 1] 내지 [치환기 52]로 표시되는 군으로부터 선택되는 어느 하나로 표시될 수 있으나, 이에 한정된 것은 아니다.The amine group bonded to A in the formulas (1) and (2) may be represented by any one selected from the group consisting of the following [substituents 1] to [52], but is not limited thereto.
[치환기1] [치환기2] [치환기3] [Substituent 1] [Substituent 2] [Substituent 3]
[치환기4] [치환기5] [치환기6] [Substituent group 4] [Substituent group 5] [Substituent group 6]
[치환기7] [치환기8] [치환기9] [Substituent group 7] [Substituent group 8] [Substituent group 9]
[치환기10] [치환기11] [치환기12] [Substituent 10] [Substituent group 11] [Substituent group 12]
[치환기13] [치환기14] [치환기15] [Substituent group 13] [Substituent group 14] [Substituent 15]
[치환기16] [치환기17] [치환기18] [Substituent group 16] [Substituent group 17] [Substituent 18]
[치환기19] [치환기20] [치환기21] [Substituent group 19] [Substituent group 20] [Substituent group 21]
[치환기22] [치환기23] [치환기24] [Substituent 22] [Substituent group 23] [Substituent group 24]
[치환기25] [치환기26] [치환기27][Substituent 25] [Substituent 26] [Substituent 27]
[치환기28] [치환기29] [치환기30][Substituent 28] [Substituent group 29] [Substituent group 30]
[치환기31] [치환기32] [치환기33][Substituent 31] [Substituent group 32] [Substituent group 33]
[치환기34] [치환기35] [치환기36][Substituent 34] [Substituent 35] [Substituent 36]
[치환기37] [치환기38] [치환기39] [Substituent group 37] [Substituent group 38] [Substituent group 39]
[치환기40] [치환기41] [치환기42][Substituent 40] [Substituent 41] [Substituent 42]
[치환기43] [치환기44] [치환기45] [Substituent 43] [Substituent 44] [Substituent 45]
[치환기46] [치환기47] [치환기48][Substituent group 46] [Substituent group 47] [Substituent group 48]
[치환기49] [치환기50] [치환기51] [Substituent 49] [Substituent group 50] [Substituent group 51]
[치환기52] [Substituent 52]
상기 치환기에서 R은 서로 동일하거나 독립적으로, 수소, 중수소, 할로겐 원자, 히드록실기, 시아노기, 니트로기, 아미노기, 아미디노기, 히드라진, 히드라존, 카르복실기나 이의 염, 술폰산기나 이의 염, 인산이나 이의 염, 치환 또는 비치환된 탄소수 1 내지 60의 알킬기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐기, 치환 또는 비치환된 탄소수 1 내지 60의 알콕시기, 치환 또는 비치환된 탄소수 1 내지 60의 알킬티오기(alkylthio), 치환 또는 비치환된 탄소수 3 내지 60의 시클로알킬기, 치환 또는 비치환된 탄소수 6 내지 60의 아릴기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴옥시기, 치환 또는 비치환된 탄소수 5 내지 60의 아릴싸이오기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 60의 (알킬)아미노기, 디(치환 또는 비치환된 탄소수 1 내지 60의 알킬)아미노기, 또는 (치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기, 디(치환 또는 비치환된 탄소수 6 내지 60의 아릴)아미노기, 치환 또는 비치환 된 탄소수 1 내지 40의 알킬실릴기, 치환 또는 비치환 된 탄소수 6 내지 30의 아릴실릴기, 게르마늄, 인, 보론 중에서 선택될 수 있으며, 각각 1에서 12개까지 치환될 수 있고, 각각의 치환기는 서로 인접하는 기와 축합 고리를 형성할 수 있다.In the above substituents, R may be the same or different from each other and is selected from the group consisting of hydrogen, deuterium, halogen atom, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine, hydrazone, carboxyl group or salt thereof, A substituted or unsubstituted alkyl group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 60 carbon atoms, a substituted or unsubstituted alkynyl group having 2 to 60 carbon atoms, a substituted or unsubstituted C1- A substituted or unsubstituted alkylthio group having 1 to 60 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 60 carbon atoms, a substituted or unsubstituted aryl group having 6 to 60 carbon atoms, a substituted or unsubstituted C1 to C60 alkoxy group, A substituted or unsubstituted arylthio group having 5 to 60 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms, a substituted or unsubstituted arylthio group having 5 to 60 carbon atoms, (Substituted or unsubstituted alkyl having 1 to 60 carbon atoms) amino group, or a substituted or unsubstituted aryl (having 6 to 60 carbon atoms) amino group, di (substituted or unsubstituted A substituted or unsubstituted alkylsilyl group having 1 to 40 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 30 carbon atoms, germanium, phosphorus, and boron, and each has 1 To 12 carbon atoms, and each of the substituents may form a condensed ring with adjacent groups.
또한 상기 발광층은 상기 도판트와 호스트이외에도 다양한 호스트와 다양한 도펀트 물질을 추가로 포함할 수 있다.The light emitting layer may further include various dopants and various hosts as well as the dopant and the host.
본 발명에 따른 상기 발광층이 호스트 및 도펀트를 포함할 경우, 도펀트의 함량은 통상적으로 호스트 약 100 중량부를 기준으로 하여 약 0.01 내지 약 20 중량부의 범위에서 선택될 수 있으며, 이에 한정되는 것은 아니다.When the light emitting layer according to the present invention includes a host and a dopant, the dopant may be selected from the range of about 0.01 to about 20 parts by weight based on 100 parts by weight of the host, but is not limited thereto.
한편, 본 발명에서 사용되는 전자 수송층은 화학식 F로 표시되는 유기 금속 화합물이 본 발명의 상기 유기 화합물 재료와 혼합으로 사용되거나, 또는 상기 화학식 A 또는 화학식 B로 표시되는 유기화합물이 사용되지 않는 경우에는 상기 화학식 F로 표시되는 유기금속 화합물이 단독으로 사용될 수 있다. On the other hand, in the electron transport layer used in the present invention, when the organometallic compound represented by the formula (F) is used in combination with the organic compound material of the present invention, or when the organic compound represented by the above formula (A) or The organometallic compound represented by Formula F may be used singly.
[화학식 F] [Chemical Formula F]
상기 [화학식 F]에서, In the above formula (F)
Y는 C, N, O 및 S에서 선택되는 어느 하나가 상기 M에 직접결합되어 단일결합을 이루는 부분과, C, N, O 및 S에서 선택되는 어느 하나가 상기 M에 배위결합을 이루는 부분을 포함하며, 상기 단일결합과 배위결합에 의해 킬레이트된 리간드이고; 상기 M은 알카리 금속, 알카리 토금속, 알루미늄(Al) 또는 붕소(B)원자이고, 상기 OA는 상기 M과 단일결합 또는 배위결합 가능한 1가의 리간드로서,Y is a moiety selected from C, N, O and S, which is directly bonded to M to form a single bond, and any moiety selected from C, N, O and S is a moiety coordinating to M And is a ligand chelated by coordination bond with the single bond; Wherein M is an alkali metal, an alkaline earth metal, an aluminum (Al), or a boron (B) atom, and OA is a monovalent ligand capable of single bond or coordination bond with M,
상기 O는 산소이며,O is oxygen,
A는 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 20의 알키닐기, 치환 또는 비치환된 탄소수 3 내지30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기 및 치환 또는 비치환되고 이종 원자로 O, N 또는 S를 갖는 탄소수 2 내지 50의 헤테로아릴기중에서 선택되는 어느 하나이고, A represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, a substituted or unsubstituted C2 to C20 Substituted or unsubstituted cycloalkyl groups having 3 to 30 carbon atoms, substituted or unsubstituted cycloalkenyl groups having 5 to 30 carbon atoms, and substituted or unsubstituted hetero atoms having 2 to 50 carbon atoms having O, N or S, An aryl group,
상기 M이 알카리 금속에서 선택되는 하나의 금속인 경우에는 m=1, n=0이고,M is 1 and n is 0 when M is a metal selected from an alkali metal,
상기 M이 알카리 토금속에서 선택되는 하나의 금속인 경우에는 m=1, n=1이거나, 또는 m=2, n=0이고, M = 1, n = 1, or m = 2 and n = 0 when M is a metal selected from alkaline earth metals,
상기 M이 붕소 또는 알루미늄인 경우에는 m = 1 내지 3중 어느 하나이며, n은 0 내지 2 중 어느 하나로서 m +n=3을 만족한다. M is 1 to 3 when M is boron or aluminum, and n is any of 0 to 2 and satisfies m + n = 3.
본 발명에서 Y 는 각각 동일하거나 상이하며, 서로 독립적으로 하기 [구조식 C1] 내지 [구조식 C39]부터 선택되는 어느 하나일 수 있으나, 이에 한정된 것은 아니다.In the present invention, Y may be the same or different and independently of each other may be any one selected from the following formulas [C1] to [C39], but is not limited thereto.
[구조식 C1] [구조식 C2] [구조식 C3][Structural formula C1] [Structural formula C2] [Structural formula C3]
[구조식 C4] [구조식 C5] [구조식 C6][Structural formula C4] [Structural formula C5] [Structural formula C6]
[구조식 C7] [구조식 C8] [구조식 C9] [구조식 C10][Structural formula C7] [Structural formula C8] [Structural formula C9] [Structural formula C10]
[구조식 C11] [구조식 C12] [구조식 C13][Structural formula C11] [Structural formula C12] [Structural formula C13]
[구조식 C14] [구조식 C15] [구조식 C16][Structural formula C14] [Structural formula C15] [Structural formula C16]
[구조식 C17] [구조식 C18] [구조식 C19] [구조식 C20][Structural formula C17] [Structural formula C18] [Structural formula C19] [Structural formula C20]
[구조식 C21] [구조식 C22] [구조식 C23][Structural formula C21] [Structural formula C22] [Structural formula C23]
[구조식 C24] [구조식 C25] [구조식 C26][Structural formula C24] [Structural formula C25] [Structural formula C26]
[구조식 C27] [구조식 C28] [구조식 C29] [구조식 C30][Structural formula C27] [Structural formula C28] [Structural formula C29] [Structural formula C30]
[구조식 C31] [구조식 C32] [구조식 C33][Structural formula C31] [Structural formula C32] [Structural formula C33]
[구조식 C34] [구조식 C35] [구조식 C36][Structural formula C34] [Structural formula C35] [Structural formula C36]
[구조식 C37] [구조식 C38] [구조식 C39] [Structural formula C37] [Structural formula C38] [Structural formula C39]
상기 [구조식 C1] 내지 [구조식 C39]에서,In the above Structural Formula C1 to Structural Formula C39,
R은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아미노기, 치환 또는 비치환된 탄소수 1 내지 30이 알킬실릴기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴아미노기 및 치환 또는 비치환된 탄소수 6 내지 30의 아릴실릴기 중에서 선택되고, 인접한 치환체와 알킬렌 또는 알케닐렌으로 연결되어 스피로고리 또는 융합고리를 형성할 수 있다. 단, 여기서 상기 ‘치환 또는 비치환된’에서의 ‘치환’은 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 알킬기, 알콕시기, 알킬아미노기, 아릴아미노기, 헤테로 아릴아미노기, 알킬실릴기, 아릴실릴기, 아릴옥시기, 아릴기, 헤테로아릴기, 게르마늄, 인 및 보론으로 이루어진 군에서 선택된 1개 이상의 치환기로 치환되는 것을 의미한다. R is the same or different and is each independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, substituted or unsubstituted C1-30 alkyl, substituted or unsubstituted C6-30 aryl, A substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C2-C30 alkenyl group, a substituted or unsubstituted C1-C30 alkoxy group, A substituted or unsubstituted alkylsilyl group having 1 to 30 carbon atoms, a substituted or unsubstituted arylamino group having 6 to 30 carbon atoms, and a substituted or unsubstituted arylsilyl group having 6 to 30 carbon atoms And may be connected to an adjacent substituent by alkylene or alkenylene to form a spiro ring or a fused ring. Herein, the 'substitution' in the 'substituted or unsubstituted' refers to a substituent selected from the group consisting of deuterium, cyano group, halogen group, hydroxyl group, nitro group, alkyl group, alkoxy group, alkylamino group, arylamino group, heteroarylamino group, An aryl group, a heteroaryl group, germanium, phosphorus, and boron. The term " substituted aryl group "
한편, 상기 전자수송층의 상부에는 캐소드로부터의 전자 주입을 용이하게 해주어 궁극적으로 파워효율을 개선시키는 기능을 수행하는 전자주입층(EIL, Electron Injecting Layer)을 더 적층시킬 수도 있는데, 상기 전자주입층 재료 역시 당해 기술분야에서 통상적으로 사용되는 것이면 특별한 제한없이 사용할 수 있으며, 예를 들어, LiF, NaCl, CsF, Li2O, BaO등의 물질을 이용할 수 있다.Meanwhile, an electron injection layer (EIL) may be further formed on the electron transport layer to facilitate injection of electrons from the cathode to ultimately improve power efficiency. The electron injection layer material As long as it is commonly used in the related art, it can be used without any particular limitation. For example, materials such as LiF, NaCl, CsF, Li 2 O, and BaO can be used.
상기 전자 주입층 형성 재료로는 CsF, NaF, LiF, NaCl, Li2O, BaO등과 같은 전자주입층 형성 재료로서 공지된 임의의 물질을 이용할 수 있다. 상기 전자주입층의 증착조건은 사용하는 화합물에 따라 다르지만, 일반적으로 정공 주입층의 형성과 거의 동일한 조건범위 중에서 선택될 수 있다.As the electron injection layer forming material, any material known as an electron injection layer forming material such as CsF, NaF, LiF, NaCl, Li 2 O, BaO, or the like can be used. The deposition conditions of the electron injection layer may vary depending on the compound used, but may generally be selected from the same range of conditions as the formation of the hole injection layer.
상기 전자 주입층의 두께는 약 1 Å 내지 약 100 Å, 약 3 Å 내지 약 90 Å일 수 있다. 상기 전자 주입층의 두께가 전술한 바와 같은 범위를 만족할 경우, 실질적인 구동 전압 상승없이 만족스러운 정도의 전자 주입 특성을 얻을 수 있다.The thickness of the electron injecting layer may be from about 1 A to about 100 A, and from about 3 A to about 90 A. When the thickness of the electron injection layer satisfies the above-described range, satisfactory electron injection characteristics can be obtained without substantially increasing the driving voltage.
또한, 본 발명에서 상기 음극은 리튬(Li), 마그네슘(Mg), 알루미늄(Al), 알루미늄-리듐(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag) 등의 음극 형성용 금속으로는 사용하거나, 또는 전면 발광 소자를 얻기 위해서는 ITO, IZO를 사용한 투과형 음극을 사용하여 형성할 수 있다.In the present invention, the negative electrode may be formed of a material selected from the group consisting of Li, Mg, Al, Al-Li, Ca, Mg- Mg-Ag), or a transmissive negative electrode using ITO or IZO can be used to obtain a top-emitting device.
또한, 본 발명에서 상기 정공 주입층, 정공 수송층, 정공 주입 기능 및 정공 수송 기능을 동시에 갖는 기능층, 발광층, 전자 수송층, 및 전자 주입층으로부터 선택된 하나 이상의 층은 증착공정 또는 용액공정에 의하여 형성될 수 있다. In the present invention, at least one layer selected from the functional layer having the hole injection layer, the hole transport layer, the hole injection function and the hole transport function, the light emitting layer, the electron transport layer, and the electron injection layer may be formed by a deposition process or a solution process .
여기서 상기 증착 방식은 상기 각각의 층을 형성하기 위한 재료로 사용되는 물질을 진공 또는 저압상태에서 가열 등을 통해 증발시켜 박막을 형성하는 방법을 의미하고, 상기 용액공정은 상기 각각의 층을 형성하기 위한 재료로 사용되는 물질을 용매와 혼합하고 이를 잉크젯 인쇄, 롤투롤 코팅, 스크린 인쇄, 스프레이 코팅, 딥 코팅, 스핀 코팅 등과 같은 방법을 통하여 박막을 형성하는 방법을 의미한다. Here, the deposition method refers to a method of forming a thin film by evaporating a material used as a material for forming each of the layers through heating or the like under vacuum or low pressure, Refers to a method of mixing a material used as a material with a solvent and forming the thin film by a method such as inkjet printing, roll-to-roll coating, screen printing, spray coating, dip coating, spin coating or the like.
또한 본 발명에서의 상기 유기발광소자는 평판 디스플레이 장치; 플렉시블 디스플레이 장치; 단색 또는 백색의 평판 조명용 장치; 및, 단색 또는 백색의 플렉시블 조명용 장치;에서 선택되는 어느 하나의 장치에 사용될 수 있다.Further, the organic light emitting device of the present invention may be a flat panel display device; A flexible display device; Monochrome or white flat panel illumination devices; And a single-color or white-colored flexible lighting device.
이하 본 발명의 유기 발광 소자를 도 1을 통해 설명하고자 한다.Hereinafter, the organic light emitting device of the present invention will be described with reference to FIG.
도 1은 본 발명의 유기 발광 소자의 구조를 나타내는 단면도이다. 본 발명에 따른 유기 발광 소자는 애노드(20), 정공수송층(40), 유기발광층(50), 전자수송층(60) 및 캐소드(80)을 포함하며, 필요에 따라 정공주입층(30)과 전자주입층(70)을 더 포함할 수 있으며, 그 이외에도 1층 또는 2층의 중간층을 더 형성하는 것도 가능하며, 정공저지층 또는 전자저지층을 더 형성시킬 수도 있다. 1 is a cross-sectional view showing a structure of an organic light emitting device of the present invention. The organic light emitting device according to the present invention includes an
도 1을 참조하여 본 발명의 유기 발광 소자 및 그 제조방법에 대하여 살펴보면 다음과 같다. 먼저 기판(10) 상부에 애노드 전극용 물질을 코팅하여 애노드(20)를 형성한다. 여기에서 기판(10)으로는 통상적인 유기 EL 소자에서 사용되는 기판을 사용하는데 투명성, 표면 평활성, 취급용이성 및 방수성이 우수한 유기 기판 또는 투명 플라스틱 기판이 바람직하다. 그리고, 애노드 전극용 물질로는 투명하고 전도성이 우수한 산화인듐주석(ITO), 산화인듐아연(IZO), 산화주석(SnO2), 산화아연(ZnO) 등을 사용한다.Referring to FIG. 1, the organic light emitting device of the present invention and a method of manufacturing the same will be described below. First, an anode electrode material is coated on the
상기 애노드(20) 전극 상부에 정공 주입층 물질을 진공열 증착, 또는 스핀 코팅하여 정공주입층(30)을 형성한다. 그 다음으로 상기 정공주입층(30)의 상부에 정공수송층 물질을 진공 열증착 또는 스핀 코팅하여 정공수송층(40)을 형성한다.A
이어서, 상기 정공수송층(40)의 상부에 유기발광층(50)을 적층하고 상기 유기발광층(50)의 상부에 선택적으로 정공저지층(미도시)을 진공 증착 방법, 또는 스핀 코팅 방법으로서 박막을 형성할 수 있다. 상기 정공저지층은 정공이 유기발광층을 통과하여 캐소드로 유입되는 경우에는 소자의 수명과 효율이 감소되기 때문에 HOMO(Highest Occupied Molecular Orbital) 레벨이 매우 낮은 물질을 사용함으로써 이러한 문제를 방지하는 역할을 한다. 이 때, 사용되는 정공 저지 물질은 특별히 제한되지는 않으나 전자수송능력을 가지면서 발광 화합물보다 높은 이온화 포텐셜을 가져야 하며 대표적으로 BAlq, BCP, TPBI 등이 사용될 수 있다.A hole blocking layer (not shown) is selectively formed on the organic
이러한 정공저지층 위에 전자수송층(60)을 진공 증착 방법, 또는 스핀 코팅 방법을 통해 증착한 후에 전자주입층(70)을 형성하고 상기 전자주입층(70)의 상부에 캐소드 형성용 금속을 진공 열증착하여 캐소드(80) 전극을 형성함으로써 유기 EL 소자가 완성된다. 여기에서 캐소드 형성용 금속으로는 리튬(Li), 마그네슘(Mg), 알루미늄(Al), 알루미늄-리듐(Al-Li), 칼슘(Ca), 마그네슘-인듐(Mg-In), 마그네슘-은(Mg-Ag) 등을 사용할 수 있으며, 전면 발광 소자를 얻기 위해서는 ITO, IZO를 사용한 투과형 캐소드를 사용할 수 있다.After the
이하, 바람직한 실시예를 들어 본 발명을 더욱 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이에 의하여 제한되지 않는다는 것은 당업계의 통상의 지식을 가진 자에게 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to preferred embodiments. It will be apparent, however, to those skilled in the art that these embodiments are for further explanation of the present invention and that the scope of the present invention is not limited thereby.
합성예 1. 화합물 1의 합성Synthesis Example 1. Synthesis of Compound 1
합성예 1-1. <중간체 1-a>의 합성Synthesis Example 1-1. Synthesis of <Intermediate 1-a>
하기 반응식 1에 의하여 <중간체 1-a>를 합성하였다.<Intermediate 1-a> was synthesized by the following Reaction Scheme 1.
[반응식 1][Reaction Scheme 1]
<중간체 1-a> <Intermediate 1-a>
1L 둥근 바닥 플라스크 반응기에 4-브로모-2-아이오도벤조에이트 (31.7g, 93 mmol), 페닐보론산 (20g, 164 mmol), 탄산칼륨 (26.4g, 191 mmol), 테트라키스트리페닐포스핀팔라듐 (2.2g, 2 mmol), 물 80 mL, 톨루엔 150 mL 및 1,4-다이옥산 150 mL를 넣고 12 시간 동안 환류 교반한다. 반응 종결 후 반응물을 층 분리하여 유기층을 감압 농축하고 컬럼크로마토그래피로 분리하여 <중간체 1-a> (21.5g, 79.4%)을 얻었다.4-bromo-2-iodobenzoate (31.7 g, 93 mmol), phenylboronic acid (20 g, 164 mmol), potassium carbonate (26.4 g, 191 mmol), tetrakis triphenylphosphine (2.2 g, 2 mmol), water (80 mL), toluene (150 mL) and 1,4-dioxane (150 mL), and the mixture was refluxed for 12 hours. After the completion of the reaction, the reaction product was separated, and the organic layer was concentrated under reduced pressure. The resultant product was separated by column chromatography to obtain <Intermediate 1-a> (21.5 g, 79.4%).
합성예 1-2. <중간체 1-b>의 합성Synthesis Example 1-2. Synthesis of <Intermediate 1-b>
하기 반응식 2 에 의하여 <중간체 1-b>를 합성하였다.<Intermediate 1-b> was synthesized by the following Reaction Scheme 2.
[반응식 2][Reaction Scheme 2]
<중간체 1-a> <중간체 1-b><Intermediate 1-a> <Intermediate 1-b>
건조된 300 mL 둥근 바닥플라스크 반응기에 질소 분위기 하에서 <중간체 1-a> (15g, 52mmol)과 테트라 하이드로 퓨란 100 mL을 넣고 0℃에서 메틸마그네슘 브로마이드 (10mL, 300 mmol) 을 적가 한다. 적가 완료 후 상온에서 3시간 동안 교반 한다. 반응 종결 후 0℃에서 2 N-HCl 수용액 100 mL를 넣고 30분 동안 교반 한다. 에틸아세테이트로 층 분리 하여 유기층을 농축하고 바로 초산 100 mL와 염산 10 mL을 넣고 10시간 동안 환류 교반 한다. 반응 종결 후 과량의 물을 넣고 30분 교반 후 여과하고 컬럼크로마토그래피로 분리하여 <중간체 1-b>(12.1g, 86%)을 얻었다. <Intermediate 1-a> (15 g, 52 mmol) and 100 mL of tetrahydrofuran are added to a dry 300 mL round-bottom flask reactor under nitrogen atmosphere, and methyl magnesium bromide (10 mL, 300 mmol) is added dropwise at 0 ° C. After completion of dropwise addition, the mixture is stirred at room temperature for 3 hours. After completion of the reaction, add 100 mL of 2 N HCl aqueous solution at 0 ° C and stir for 30 minutes. The layers were separated with ethyl acetate, and the organic layer was concentrated. Immediately, 100 mL of acetic acid and 10 mL of hydrochloric acid were added, and the mixture was refluxed with stirring for 10 hours. After completion of the reaction, excess water was added and stirred for 30 minutes, followed by filtration and separation by column chromatography to obtain <Intermediate 1-b> (12.1 g, 86%).
합성예 1-3. <중간체 1-c>의 합성Synthesis Example 1-3. Synthesis of <Intermediate 1-c>
하기 반응식 3 에 의하여 <중간체 1-c>를 합성하였다.<Intermediate 1-c> was synthesized by the following Reaction Scheme 3.
[반응식 3][Reaction Scheme 3]
<중간체 1-b> <중간체 1-c><Intermediate 1-b> <Intermediate 1-c>
건조된 1 L 둥근 바닥플라스크 반응기에 <중간체 1-b> (42g, 154 mmol)을 질소 기류하에서 테트라하이드로퓨란 420 mL에 녹인 후 영하 78 ℃에서 교반하면서 1.6 M 노르말-부틸리튬(155 mL, 247 mmol)을 천천히 적가한다. 적가가 완료되면 영하 78℃를 유지하면서 1시간 반 동안 교반한다. 그 후 트리메틸보레이트 (30.8g, 297 mmol)를 천천히 적가한 후 상온으로 올려서 1 시간 동안 교반한다. 반응 종료 후 2 N 염산수용액 200 mL를 상온에서 적가한 후 30분 동안 교반한다. 그 후 에틸아세테이트와 물로 추출하고 유기층을 감압농축하고 재결정하여 <중간체 1-c> (34g, 93%)를 얻었다. <Intermediate 1-b> (42 g, 154 mmol) was dissolved in 420 mL of tetrahydrofuran in a nitrogen stream, and 1.6 M n-butyl lithium (155 mL, 247 mmol) is slowly added dropwise. When dropping is completed, stirring is continued for 1 hour and a half while maintaining the temperature at -78 ° C. After that, trimethyl borate (30.8 g, 297 mmol) was slowly added dropwise thereto, and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, 200 mL of a 2N hydrochloric acid aqueous solution is added dropwise at room temperature, followed by stirring for 30 minutes. The mixture was extracted with ethyl acetate and water. The organic layer was concentrated under reduced pressure and recrystallized to obtain <Intermediate 1-c> (34 g, 93%).
합성예 1-4. <중간체 1-d>의 합성Synthesis Example 1-4. Synthesis of <Intermediate 1-d>
하기 반응식 4에 의하여 <중간체 1-d>를 합성하였다.<Intermediate 1-d> was synthesized by the following Reaction Scheme 4.
[반응식 4][Reaction Scheme 4]
<중간체 1-c> <중간체 1-d> <Intermediate 1-c> <Intermediate 1-d>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 2,5-디브로모벤즈알데히드를 사용하고 페닐보론산 대신 <중간체 1-c>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 1-d> (21.3g, 71%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-1, except that 2,5-dibromobenzaldehyde was used instead of 4-bromo-2-iodobenzoate and Intermediate 1-c> was used in place of phenylboronic acid <Intermediate 1-d> (21.3 g, 71%).
합성예 1-5. <중간체 1-e>의 합성Synthesis Example 1-5. Synthesis of <Intermediate 1-e>
하기 반응식 5에 의하여 <중간체 1-e>를 합성하였다.Intermediate 1-e > was synthesized by the following Reaction Scheme 5.
[반응식 5][Reaction Scheme 5]
<중간체 1-d> <중간체 1-e><Intermediate 1-d> <Intermediate 1-e>
2L 둥근 바닥플라스크 반응기에 포타슘 터셔리 부톡사이드 (23.4g, 192 mmol), 테트라하이드로 퓨란 200 ml을 넣고 교반시킨 후 질소 분위기하에서 0℃ 로 냉각시킨다. 메톡시메틸 트라이페닐포스포늄 클로라이드 (65.8g, 192mmol) 을 테트라하이드로퓨란 300 ml에 녹여 적가한 후 30분간 교반시킨다. <중간체 1-d> (47g, 125mmol)을 테트라하이드로퓨란 500 ml에 녹여 천천히 넣어준 후 상온에서 2시간 교반한다. 반응종료 후 에틸아세테이트와 물로 추출한 후 유기층을 감압농축하고 컬럼크로마토그래피로 분리하여 <중간체1-e> (46.5g, 92%)을 얻었다. To a 2 L round bottom flask reactor was added potassium tertiary butoxide (23.4 g, 192 mmol) and tetrahydrofuran (200 ml), stirred and cooled to 0 ° C under a nitrogen atmosphere. Methoxymethyltriphenylphosphonium chloride (65.8 g, 192 mmol) was dissolved in 300 ml of tetrahydrofuran, and the mixture was stirred for 30 minutes. <Intermediate 1-d> (47 g, 125 mmol) was dissolved in 500 ml of tetrahydrofuran, and the mixture was stirred at room temperature for 2 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate and water, and the organic layer was concentrated under reduced pressure. The resultant product was separated by column chromatography to obtain <Intermediate 1-e> (46.5 g, 92%).
합성예 1-6. <중간체 1-f>의 합성Synthesis Example 1-6. Synthesis of <Intermediate 1-f>
하기 반응식 6에 의하여 <중간체 1-f>를 합성하였다.<Intermediate 1-f> was synthesized by the following Reaction Scheme 6.
[반응식 6][Reaction Scheme 6]
<중간체 1-e> <중간체 1-f><Intermediate 1-e> <Intermediate 1-f>
1L 둥근 바닥플라스크 반응기에 질소분위기 하에서 <중간체 1-e> (46g, 114 mmol), 비스머스(III) 트리플루오로 메탄설포네이트 (3.8g, 5.8 mmol), 1,2-디클로로에탄 500 ml를 넣고 상온에서 3시간 교반한다. 반응 종료 후 메탄올을 사용하여 침전물을 형성시키고 고체를 여과하여 <중간체 1-f> (37.8g, 89%)를 얻었다. (46 g, 114 mmol), Bismuth (III) trifluoromethanesulfonate (3.8 g, 5.8 mmol) and 500 ml of 1,2-dichloroethane were added to a 1 L round bottom flask reactor under nitrogen atmosphere And the mixture is stirred at room temperature for 3 hours. After completion of the reaction, methanol was used to form a precipitate, and the solid was filtered to obtain <Intermediate 1-f> (37.8 g, 89%).
합성예 1-7. <중간체 1-g>의 합성Synthesis Example 1-7. Synthesis of <Intermediate 1-g>
하기 반응식 7에 의하여 <중간체 1-g>를 합성하였다.<Intermediate 1-g> was synthesized according to the following Reaction Scheme 7.
[반응식 7][Reaction Scheme 7]
<중간체 1-f> <중간체 1-g><Intermediate 1-f> <Intermediate 1-g>
합성예 1-3에서 <중간체1-b> 대신 <중간체 1-f>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 1-g> (31.3g, 81%)을 얻었다.Intermediate 1-g> (31.3 g, 81%) was obtained in the same manner as in Synthesis Example 1-3, except that Intermediate 1-f was used instead of Intermediate 1-b.
합성예 1-8. <화합물 1>의 합성Synthesis Example 1-8. Synthesis of Compound 1
하기 반응식 8에 의하여 <화합물 1>를 합성하였다.<Compound 1> was synthesized by the following Reaction Scheme 8.
[반응식 8][Reaction Scheme 8]
<중간체 1-g> <화합물 1> <Intermediate 1-g> <Compound 1>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 2-클로로-4,6-디페닐-1,3,5-트리아진을 사용하고 페닐보론산 대신 <중간체 1-g>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 1> (3.7g, 41%)을 얻었다. Synthesis Example 1-1 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine was used instead of 4-bromo-2-iodobenzoate and Intermediate 1-g> Was used to synthesize <compound 1> (3.7 g, 41%).
MS (MALDI-TOF) : m/z 525.22[M+]MS (MALDI-TOF): m / z 525.22 [M < + >
합성예 2. 화합물 9의 합성Synthesis Example 2. Synthesis of Compound 9
합성예 2-1. <중간체 2-a>의 합성Synthesis Example 2-1. Synthesis of <Intermediate 2-a>
하기 반응식 9에 의하여 <중간체 2-a>를 합성하였다.<Intermediate 2-a> was synthesized by the following Reaction Scheme 9.
[반응식 9][Reaction Scheme 9]
<중간체 1-c> <중간체 2-a> <Intermediate 1-c> <Intermediate 2-a>
합성예 1-4에서 2,5-디브로모벤즈알데히드 대신 2,6-디브로모벤즈알데히드를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 2-a> (23.3g, 69.1%)을 얻었다.The procedure of Synthesis Example 1-4 was repeated except that 2,6-dibromobenzaldehyde was used instead of 2,5-dibromobenzaldehyde to obtain Intermediate 2-a (23.3 g, 69.1%).
합성예Synthetic example 2-2. <중간체 2-b>의 합성 2-2. Synthesis of <Intermediate 2-b>
하기 반응식 10에 의하여 <중간체 2-b>를 합성하였다.<Intermediate 2-b> was synthesized by the following
[반응식 10][Reaction Scheme 10]
<중간체 2-a> <중간체 2-b>≪ Intermediate 2-a > < Intermediate 2-b &
합성예 1-5에서 <중간체 1-d> 대신 <중간체 2-a>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 2-b> (18.6g, 82.1%)을 얻었다. Intermediate 2-b> (18.6 g, 82.1%) was obtained in the same manner as in Synthesis Example 1-5, except that <Intermediate 2-a> was used instead of <Intermediate 1-d>.
합성예Synthetic example 2-3. <중간체 2-c>의 합성 2-3. Synthesis of <Intermediate 2-c>
하기 반응식 11에 의하여 <중간체 2-c>를 합성하였다.≪ Intermediate 2-c > was synthesized by the following Reaction Scheme 11.
[반응식 11][Reaction Scheme 11]
<중간체 2-b> <중간체 2-c><Intermediate 2-b> <Intermediate 2-c>
합성예 1-6에서 <중간체 1-e> 대신 <중간체 2-b>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 2-c> (15.6g, 85.1%)을 얻었다.Intermediate 2-c > (15.6 g, 85.1%) was obtained in the same manner except that Intermediate 2-b was used instead of Intermediate 1-e in Synthesis Example 1-6.
합성예Synthetic example 2-4. <중간체 2-d>의 합성 2-4. Synthesis of <Intermediate 2-d>
하기 반응식 12에 의하여 <중간체 2-d>를 합성하였다.<Intermediate 2-d> was synthesized according to the following Reaction Scheme 12.
[반응식 12][Reaction Scheme 12]
<중간체 2-c> <중간체 2-d><Intermediate 2-c> <Intermediate 2-d>
합성예 1-3에서 <중간체 1-b> 대신 <중간체 2-c>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 2-d> (15.4g, 82.1%)을 얻었다. Intermediate 2-d> (15.4 g, 82.1%) was obtained in the same manner as in Synthesis Example 1-3, except that <Intermediate 2-c> was used instead of <Intermediate 1-b>.
합성예Synthetic example 2-5. <화합물 2-5. <Compound 9>의9> 합성 synthesis
하기 반응식 13에 의하여 <화합물 9>를 합성하였다.<Compound 9> was synthesized according to the following Reaction Scheme 13.
[반응식 13][Reaction Scheme 13]
<중간체 2-d> <화합물 9> <Intermediate 2-d><Compound9>
합성예 1-8에서 <중간체 1-g> 대신 <중간체 2-d>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 9> (4.1g, 44.2%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-8, except that <Intermediate 2-d> was used instead of <Intermediate 1-g> to obtain Compound 9 (4.1 g, 44.2%).
MS (MALDI-TOF) : m/z 525.22[M+]MS (MALDI-TOF): m / z 525.22 [M < + >
합성예Synthetic example 3. 화합물 13의 합성 3. Synthesis of Compound 13
합성예Synthetic example 3-1. <중간체 3-a>의 합성 3-1. Synthesis of <Intermediate 3-a>
하기 반응식 14에 의하여 <중간체 3-a>를 합성하였다.Intermediate 3-a > was synthesized according to the following Reaction Scheme 14.
[반응식 14][Reaction Scheme 14]
<중간체 1-c> <중간체 3-a> <Intermediate 1-c> <Intermediate 3-a>
합성예 1-4에서 2,5-디브로모벤즈알데히드 대신 2-브로모벤즈알데히드를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 3-a> (24.3g, 72.1%)을 얻었다.The procedure of Synthesis Example 1-4 was repeated except that 2-bromobenzaldehyde was used instead of 2,5-dibromobenzaldehyde to obtain Intermediate 3-a (24.3 g, 72.1%).
합성예Synthetic example 3-2. <중간체 3-b>의 합성 3-2. Synthesis of <Intermediate 3-b>
하기 반응식 15에 의하여 <중간체3-b>를 합성하였다.<Intermediate 3-b> was synthesized by the following Reaction Scheme 15.
[반응식 15][Reaction Scheme 15]
<중간체 3-a> <중간체 3-b>≪ Intermediate 3-a > < Intermediate 3-b &
합성예 1-5에서 <중간체 1-d> 대신 <중간체 3-a>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 3-b> (19.6g, 78.1%)을 얻었다Intermediate 3-b> (19.6 g, 78.1%) was obtained by the same method except that <Intermediate 3-a> was used instead of <Intermediate 1-d> in Synthesis Example 1-5
합성예Synthetic example 3-3. <중간체 3-c>의 합성 3-3. Synthesis of <Intermediate 3-c>
하기 반응식 16에 의하여 <중간체 3-c>를 합성하였다.Intermediate 3-c > was synthesized according to the following Reaction Scheme 16.
[반응식 16][Reaction Scheme 16]
<중간체 3-b> <중간체 3-c><Intermediate 3-b> <Intermediate 3-c>
합성예 1-6에서 <중간체 1-e> 대신 <중간체 3-b>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 3-c> (14.7g, 82.1%)을 얻었다.Intermediate 3-c> (14.7 g, 82.1%) was obtained in the same manner as in Synthesis Example 1-6, except that <Intermediate 3-b> was used instead of <Intermediate 1-e>.
합성예Synthetic example 3-4. <중간체 3-d>의 합성 3-4. Synthesis of <Intermediate 3-d>
하기 반응식 17에 의하여 <중간체 3-d>를 합성하였다.Intermediate 3-d > was synthesized by the following Reaction Scheme 17.
[반응식 17][Reaction Scheme 17]
<중간체 3-c> <중간체 3-d><Intermediate 3-c> <Intermediate 3-d>
1 L 둥근 바닥플라스크 반응기에 <중간체 3-c> (14.7g, 87.9 mmol), 디클로로메탄 150 ml를 넣고 교반한다. 상온에서 브로민 (2.5g, 102 mmol)을 천천히 적가한 후 5시간 동안 교반한다. 반응종결 후 메탄올을 사용하여 침전을 잡고 여과하여 <중간체 3-d>(17.1g, 82%)를 얻었다. <Intermediate 3-c> (14.7 g, 87.9 mmol) and 150 ml of dichloromethane are added to a 1 L round bottom flask reactor and stirred. Bromine (2.5 g, 102 mmol) was slowly added dropwise at room temperature and stirred for 5 hours. After completion of the reaction, precipitation was carried out using methanol, followed by filtration to obtain <Intermediate 3-d> (17.1 g, 82%).
합성예Synthetic example 3-5. <중간체 3-e>의 합성 3-5. Synthesis of <Intermediate 3-e>
하기 반응식 18에 의하여 <중간체 3-e>를 합성하였다.Intermediate 3-e > was synthesized by the following Reaction Scheme 18.
[반응식 18][Reaction Scheme 18]
<중간체 3-d> <중간체 3-e><Intermediate 3-d> <Intermediate 3-e>
합성예 1-3에서 <중간체 1-b> 대신 <중간체 3-d>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 3-e> (14.7g, 79.1%)을 얻었다. Intermediate 3-e> (14.7 g, 79.1%) was obtained in the same manner as in Synthesis Example 1-3, except that <Intermediate 3-d> was used instead of <Intermediate 1-b>.
합성예Synthetic example 3-6. <화합물 3-6. <Compound 13>의13> 합성 synthesis
하기 반응식 19에 의하여 <화합물 13>를 합성하였다.<Compound 13> was synthesized by the following Reaction Scheme 19.
[반응식 19][Reaction Scheme 19]
<중간체 3-e> <화합물 13> <Intermediate 3-e> <Compound 13>
합성예 1-8에서 <중간체 1-g> 대신 <중간체 3-e>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 13> (3.7g, 37.2%)을 얻었다. Compound (13) (3.7 g, 37.2%) was obtained in the same manner as in Synthesis Example 1-8, except that <Intermediate 3-e> was used instead of <Intermediate 1-g>.
MS (MALDI-TOF) : m/z 525.22[M+]MS (MALDI-TOF): m / z 525.22 [M < + >
합성예Synthetic example 4. 화합물 33의 합성 4. Synthesis of Compound 33
합성예Synthetic example 4-1. <중간체 4-a>의 합성 4-1. Synthesis of <Intermediate 4-a>
하기 반응식 20에 의하여 <중간체 4-a>를 합성하였다.<Intermediate 4-a> was synthesized according to the following
[반응식 20][Reaction Scheme 20]
<중간체4-a> <Intermediate 4-a>
건조된 2 L 둥근 바닥플라스크 반응기에 질소 분위기 하에서 에틸 시아노 아세테이트 (139.8g, 1.236 mol), 포타슘 시아나이드 (29.5g, 0.453 mol), 포타슘 하이드록사이드 (46.2g, 0.824 mol), 디메틸포름아마이드 920 mL 에 녹인 후 10 ℃ 에서 20분 동안 교반한다. 그 후 1-니트로나프탈렌 (92g, 531mol)을 반응물에 넣고 60 ℃에서 4시간 동안 교반한다. 반응 종료 후 용매를 농축하고 10% 소듐 하이드록사이드 수용액을 600 mL을 넣고 1시간 동안 환류 교반한다. 고체를 여과하고 컬럼 크로마토그래피로 분리하여 <중간체4-a> (50g, 56%)를 얻었다. A dry 2 L round bottom flask reactor was charged with ethyl cyanoacetate (139.8 g, 1.236 mol), potassium cyanide (29.5 g, 0.453 mol), potassium hydroxide (46.2 g, 0.824 mol), dimethylformamide Dissolved in 920 mL, and stirred at 10 ° C for 20 minutes. Then, 1-nitronaphthalene (92 g, 531 mol) was added to the reaction mixture and stirred at 60 ° C for 4 hours. After completion of the reaction, the solvent was concentrated, 600 mL of a 10% sodium hydroxide aqueous solution was added, and the mixture was refluxed with stirring for 1 hour. The solid was filtered and separated by column chromatography to obtain <Intermediate 4-a> (50 g, 56%).
합성예Synthetic example 4-2. <중간체 4-b>의 합성 4-2. Synthesis of <Intermediate 4-b>
하기 반응식 21에 의하여 <중간체 4-b>를 합성하였다<Intermediate 4-b> was synthesized according to the following Reaction Scheme 21
[반응식 21][Reaction Scheme 21]
<중간체4-a> <중간체 4-b>≪ Intermediate 4-a > < Intermediate 4-b &
건조된 1 L 둥근 바닥플라스크 반응기에 질소를 채워준 후 <중간체 4-a>(20.0g, 169 mmol), 테트라하이드로퓨란 200 mL을 넣고 0℃에서 3M-페닐마그네슘브로마이드 (113mL, 623mmol)를 천천히 적가한 후 3시간 환류 교반시킨다. 출발 물질이 사라지면 다시 저온으로 낮춘 후 3-브로모벤조일클로라이드 (44.58g, 0.203 mmol)을 테트라하이드로퓨란 200 mL에 녹인후 천천히 적가한 후 2시간 환류 교반 시킨다. 반응종료 후 암모늄클로라이드 수용액을 넣어 반응을 멈추고 에틸아세테이트와 물로 추출하고 유기층을 감압 농축한 후 컬럼 크로마토그래피로 분리하여 <중간체 4-b>(37g, 30.3%)을 얻었다. The reactor was filled with nitrogen, and then 3M-phenylmagnesium bromide (113 mL, 623 mmol) was slowly added dropwise at 0 ° C. to the reaction mixture with the addition of <Intermediate 4-a> (20.0 g, 169 mmol) and 200 mL of tetrahydrofuran And then refluxed for 3 hours. When the starting material disappeared, the temperature was lowered again, and then 3-bromobenzoyl chloride (44.58 g, 0.203 mmol) was dissolved in 200 mL of tetrahydrofuran, and the mixture was slowly added dropwise, followed by stirring under reflux for 2 hours. After completion of the reaction, an aqueous ammonium chloride solution was added to stop the reaction. The reaction mixture was extracted with ethyl acetate and water. The organic layer was concentrated under reduced pressure and then separated by column chromatography to obtain <Intermediate 4-b> (37 g, 30.3%).
합성예Synthetic example 4-3. <화합물 4-3. <Compound 33>의33> 합성 synthesis
하기 반응식 22에 의하여 <화합물 33>를 합성하였다<Compound 33> was synthesized by the following Reaction Formula 22
[반응식 22][Reaction Scheme 22]
<중간체 4-b> <중간체 1-g> <화합물 33> <Intermediate 4-b> <Intermediate 1-g> <Compound 33>
합성예 1-8에서 2-클로로-4,6-디페닐-1,3,5-트리아진 대신 <중간체 4-b>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 33> (4.7g, 45.1%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-8, except that <Intermediate 4-b> was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine to obtain <Compound 33> , 45.1%).
MS (MALDI-TOF) : m/z 624.26[M+]MS (MALDI-TOF): m / z 624.26 [M < + >
합성예Synthetic example 5. 화합물 44의 합성 5. Synthesis of Compound 44
합성예Synthetic example 5-1. <중간체 5-a>의 합성 5-1. Synthesis of <Intermediate 5-a>
하기 반응식 23에 의하여 <중간체 5-a>를 합성하였다.Intermediate 5-a > was synthesized according to the following Reaction Scheme 23.
[반응식 23][Reaction Scheme 23]
<중간체 5-a> <Intermediate 5-a>
2 L 반응기에 2-하이드록시 메틸페놀 (100g, 806mmol), 소듐 시아나이드 (43.4g, 886 mmol),디메틸포름아마이드 1000 mL을 넣고 120 ℃에서 4 시간 동안 교반한다. 반응 종료 후 물과 에틸아세테이트로 추출한다. 농축 후 컬럼 크로마토그래피로 분리하여 <중간체 5-a> (90g, 84%)을 얻었다. 2-Hydroxymethylphenol (100 g, 806 mmol), sodium cyanide (43.4 g, 886 mmol) and dimethylformamide (1000 mL) were added to a 2 L reactor, and the mixture was stirred at 120 ° C for 4 hours. After completion of the reaction, the reaction mixture is extracted with water and ethyl acetate. Concentrated and then separated by column chromatography to obtain <Intermediate 5-a> (90 g, 84%).
합성예Synthetic example 5-2. <중간체 5-b>의 합성 5-2. Synthesis of <Intermediate 5-b>
하기 반응식 24에 의하여 <중간체 5-b>를 합성하였다.<Intermediate 5-b> was synthesized according to the following Reaction Scheme 24.
[반응식 24][Reaction Scheme 24]
<중간체 5-a> <중간체 5-b>≪ Intermediate 5-a > < Intermediate 5-b &
2 L 반응기에 <중간체 5-a> (90g, 676 mmol), 4-디메틸아미노피리딘 (68.8g, 338 mmol), 트리에틸아민 (137g, 1352 mmol), 메틸렌클로라이드 900 mL을 넣고 0 ℃에서 벤졸클로라이드 (82.4g, 676mmol)을 적가한다. 적가 후 상온에서 4시간 동안 교반한다. 반응 종료 후 농축하고 컬럼 크로마토그래피로 분리하여 <중간체 5-b> (90g, 56%)을 얻었다.In a 2 L reactor, add <Intermediate 5-a> (90 g, 676 mmol), 4-dimethylaminopyridine (68.8 g, 338 mmol), triethylamine (137 g, 1352 mmol) and 900 mL of methylene chloride. Chloride (82.4 g, 676 mmol) is added dropwise. After the dropwise addition, the mixture is stirred at room temperature for 4 hours. After completion of the reaction, the reaction mixture was concentrated and separated by column chromatography to obtain <Intermediate 5-b> (90 g, 56%).
합성예Synthetic example 5-3. <중간체 5-c>의 합성 5-3. <Synthesis of intermediate 5-c>
하기 반응식 25에 의하여 <중간체 5-c>를 합성하였다.<Intermediate 5-c> was synthesized according to the following Reaction Scheme 25.
[반응식 25][Reaction Scheme 25]
<중간체 5-b> <중간체 5-c><Intermediate 5-b> <Intermediate 5-c>
건조된 1 L 둥근 바닥플라스크 반응기에 <중간체 5-b> (40g, 169 mmol), 트리사이클로헥실포스핀 (9.5g, 34 mmol), 아연가루 (1.9g, 17 mmol), 팔라듐아세테이트 (3.8g, 17 mmol), 디메틸포름아마이드 400 mL을 넣고 질소하에서 12시간 동안 환류 교반한다. 반응 종료 후 상온에서 과량의 물에 반응물을 적가하여 갈색 결정이 생기면 여과하고 컬럼 크로마토그래피로 분리하여 <중간체 5-c> (22g, 55%)을 얻었다.To a dry 1 L round bottom flask reactor was added <intermediate 5-b> (40 g, 169 mmol), tricyclohexylphosphine (9.5 g, 34 mmol), zinc powder (1.9 g, 17 mmol), palladium acetate , 17 mmol) and dimethylformamide (400 mL), and the mixture was refluxed under nitrogen for 12 hours. After completion of the reaction, the reaction product was added dropwise to an excess amount of water at room temperature. When brown crystals were formed, the reaction mixture was filtered and separated by column chromatography to obtain <Intermediate 5-c> (22 g, 55%).
합성예Synthetic example 5-4. <중간체 5-d>의 합성 5-4. Synthesis of <Intermediate 5-d>
하기 반응식 26에 의하여 <중간체 5-d>를 합성하였다.<Intermediate 5-d> was synthesized according to the following Reaction Scheme 26.
[반응식 26][Reaction Scheme 26]
<중간체 5-c> <중간체 5-d><Intermediate 5-c> <Intermediate 5-d>
500 mL 반응기에 <중간체 5-c> (37g, 156 mmol), 우레아 (16.9g, 281 mmol), 초산 300 mL을 넣고 12시간 동안 환류 교반한다. 반응 종료 후 과량의 물을 반응물에 넣고 석출시킨 후 여과한다. 메탄올로 뜨겁게 슬러리 후 여과하고 톨루엔으로 뜨겁게 슬러리한 후 여과 건조하여 <중간체 5-d> (24g, 59%)를 얻었다.<Intermediate 5-c> (37 g, 156 mmol), urea (16.9 g, 281 mmol) and acetic acid (300 mL) were added to a 500 mL reactor and the mixture was refluxed for 12 hours. After completion of the reaction, excess water is added to the reaction product, which is then filtered out. The mixture was hot-slurryed with methanol, filtered, hot-slurried with toluene, and then filtered to obtain <Intermediate 5-d> (24 g, 59%).
합성예Synthetic example 5-5. <중간체 5-e>의 합성 5-5. <Synthesis of intermediate 5-e>
하기 반응식 27에 의하여 <중간체 5-e>를 합성하였다.<Intermediate 5-e> was synthesized by the following Reaction Scheme 27.
[반응식 27][Reaction Scheme 27]
<중간체 5-d> <중간체 5-e><Intermediate 5-d> <Intermediate 5-e>
500 mL 반응기에 <중간체 5-d> (24g, 94 mmol), 포스포러스 옥시클로라이드 240 mL을 넣고 3시간 동안 환류 교반한다. 반응 종료 후 0 ℃의 과량의 물에 반응물을 천천히 넣고 석출시킨 후 여과한다. 컬럼 크로마토그래피로 분리하여 <중간체 5-e> (19g, 74%)을 얻었다. <Intermediate 5-d> (24 g, 94 mmol) and phosphorus oxychloride (240 mL) were added to a 500 mL reactor, and the mixture was refluxed with stirring for 3 hours. After completion of the reaction, slowly add the reactant to an excess of water at 0 ° C, precipitate it, and filter it. The intermediate was separated by column chromatography to obtain Intermediate 5-e (19 g, 74%).
합성예Synthetic example 5-6. <화합물 5-6. <Compound 44>의44> 합성 synthesis
하기 반응식 28에 의하여 <화합물 44>를 합성하였다.<Compound 44> was synthesized by the following Reaction Formula 28.
[반응식 28][Reaction Scheme 28]
<중간체 5-e> <중간체 1-g> <화합물 44> <Intermediate 5-e> <Intermediate 1-g> <Compound 44>
합성예 1-8에서 2-클로로-4,6-디페닐-1,3,5-트리아진 대신 <중간체 5-e>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 44> (4.2g, 41.1%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-8, except that <Intermediate 5-e> was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine to obtain < , 41.1%).
MS (MALDI-TOF) : m/z 538.2[M+]MS (MALDI-TOF): m / z 538.2 [M < + >
합성예Synthetic example 6. 화합물 107의 합성 6. Synthesis of Compound 107
합성예Synthetic example 6-1. <중간체 6-a>의 합성 6-1. Synthesis of <Intermediate 6-a>
하기 반응식 29에 의하여 <중간체 6-a>를 합성하였다.<Intermediate 6-a> was synthesized by the following Reaction Scheme 29.
[반응식 29][Reaction Scheme 29]
<중간체 6-a> <Intermediate 6-a>
합성예 3-4에서 <중간체 3-c> 대신 디페닐아민을 사용한 것을 제외하고는 동일한 방법을 사용하여 <중간체 6-a> (40g, 60%)를 얻었다. <Intermediate 6-a> (40 g, 60%) was obtained using the same method except that diphenylamine was used in place of <Intermediate 3-c> in Synthesis Example 3-4.
합성예Synthetic example 6-2. <중간체 6-b>의 합성 6-2. Synthesis of <Intermediate 6-b>
하기 반응식 30에 의하여 <중간체 6-b>를 합성하였다.<Intermediate 6-b> was synthesized by the following
[반응식 30][Reaction Scheme 30]
<중간체 6-a> <중간체 6-b>≪ Intermediate 6-a > < Intermediate 6-b &
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 <중간체 6-a>를 사용한 것을 제외하고는 동일한 방법을 사용하여 <중간체 6-b> (9.9g, 75.2%)를 얻었다. <Intermediate 6-b> (9.9 g, 75.2%) was obtained using the same method except that <Intermediate 6-a> was used instead of 4-bromo-2-iodobenzoate in Synthesis Example 1-1 .
합성예Synthetic example 6-3. <중간체 6-c>의 합성 6-3. Synthesis of <Intermediate 6-c>
하기 반응식 31 에 의하여 <중간체 6-c>를 합성하였다.<Intermediate 6-c> was synthesized by the following Reaction Scheme 31.
[반응식 31][Reaction Scheme 31]
<중간체 6-b> <중간체 6-c><Intermediate 6-b> <Intermediate 6-c>
250 ml 반응기에 <중간체 6-b> (7.9g, 24.6mmol), 4-브로모 아이오도벤젠 (8.3g, 30mmol), 팔라듐 아세테이트 (0.4g, 0.3mmol), 소듐터셔리 부톡사이드 (4.2g, 43mmol), 트리 터셔리 부틸포스핀 (0.1g, 0.3mmol), 톨루엔 100 ml를 넣고 13시간 동안 환류 교반 시킨다. 반응 종결 후 여과 하여 여액을 농축한다. 컬럼 크로마토그래피로 분리하여 <중간체 6-c> (4.0g, 34%)을 얻었다. To a 250 ml reactor were added <Intermediate 6-b> (7.9 g, 24.6 mmol), 4-bromoiodobenzene (8.3 g, 30 mmol), palladium acetate (0.4 g, 0.3 mmol), sodium tertiary butoxide , Tertiary butyl phosphine (0.1 g, 0.3 mmol) and toluene (100 ml) were added, and the mixture was stirred under reflux for 13 hours. After completion of the reaction, the reaction mixture is filtered and the filtrate is concentrated. The reaction mixture was separated by column chromatography to obtain <Intermediate 6-c> (4.0 g, 34%).
합성예Synthetic example 6-4. <중간체 6-d>의 합성 6-4. Synthesis of <Intermediate 6-d>
하기 반응식 32 에 의하여 <중간체 6-d>를 합성하였다.≪ Intermediate 6-d >
[반응식 32][Reaction Scheme 32]
<중간체 6-c> <중간체 6-d><Intermediate 6-c> <Intermediate 6-d>
500 mL 반응기에 <중간체 6-c> (25g, 52.5mmol), 비스피나콜라토 디보론 (12g, 132 mmol), 팔라듐(II) 염화-1,1'-비스(다이페닐포스피노)페로센 (2.5g, 3 mmol), 칼륨 아세테이트 (20.2g, 224.9 mmol), 톨루엔 250 ml를 넣고 12시간 동안 환류 교반 한다. 반응종료 후 고체를 걸러낸 후 여액을 감압하여 농축한다. 컬럼 크로마토그래피로 분리하여 <중간체 6-d> (19.4g, 71%)를 얻었다. (25 g, 52.5 mmol), bispinacolatodiboron (12 g, 132 mmol), palladium (II) chloride-1,1'-bis (diphenylphosphino) ferrocene 2.5 g, 3 mmol), potassium acetate (20.2 g, 224.9 mmol) and toluene (250 ml), and the mixture was refluxed with stirring for 12 hours. After completion of the reaction, the solid is filtered off and the filtrate is concentrated under reduced pressure. The reaction mixture was separated by column chromatography to obtain <Intermediate 6-d> (19.4 g, 71%).
합성예Synthetic example 6-5. <화합물 6-5. <Compound 107>의107> 합성 synthesis
하기 반응식 33에 의하여 <화합물 107>를 합성하였다<Compound 107> was synthesized by the following Reaction Formula 33
[반응식 33][Reaction Scheme 33]
<중간체 1-f> <중간체 6-d> <화합물 107> <Intermediate 1-f> <Intermediate 6-d> <Compound 107>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 <중간체 1-f>를 사용하고 페닐보론산 대신 <중간체 6-d>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 107> (3.9g, 31.1%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-1, except that <Intermediate 1-f> was used instead of 4-bromo-2-iodobenzoate and <Intermediate 6-d> was used instead of phenylboronic acid, 107> (3.9 g, 31.1%).
MS (MALDI-TOF) : m/z 689.31[M+]MS (MALDI-TOF): m / z 689.31 [M < + >].
합성예Synthetic example 7. 화합물 109의 합성 7. Synthesis of Compound 109
합성예Synthetic example 7-1. <중간체 7-a>의 합성 7-1. Synthesis of <Intermediate 7-a>
하기 반응식 34에 의하여 <중간체 7-a>를 합성하였다.≪ Intermediate 7-a >
[반응식 34][Reaction Scheme 34]
<중간체 7-a> <Intermediate 7-a>
합성예 6-3에서 <중간체 6-b> 대신 바이페닐-4-아민을 사용하고 4-브로모 아이오도벤젠 대신 2-브로모-9,9-디메틸-9H-플루오렌을 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 7-a> (47g, 71.2%)을 얻었다. Except that biphenyl-4-amine was used instead of <Intermediate 6-b> in Synthesis Example 6-3 and 2-bromo-9,9-dimethyl-9H-fluorene was used in place of 4-bromoiodobenzene Were synthesized in the same manner to give <Intermediate 7-a> (47 g, 71.2%).
합성예Synthetic example 7-2. <중간체 7-b>의 합성 7-2. Synthesis of <Intermediate 7-b>
하기 반응식 35에 의하여 <중간체 7-b>를 합성하였다.<Intermediate 7-b> was synthesized by the following Reaction Scheme 35.
[반응식 35][Reaction Scheme 35]
<중간체 7-a> <중간체 7-b><Intermediate 7-a> <Intermediate 7-b>
합성예 6-3에서 <중간체 6-b> 대신 <중간체 7-a>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 7-b> (34.1g, 71.1%)을 얻었다. Intermediate 7-b> (34.1 g, 71.1%) was obtained in the same manner as in Synthesis Example 6-3, except that <Intermediate 7-a> was used instead of <Intermediate 6-b>.
합성예Synthetic example 7-3. <중간체 7-c>의 합성 7-3. <Synthesis of intermediate 7-c>
하기 반응식 36에 의하여 <중간체 7-c>를 합성하였다.<Intermediate 7-c> was synthesized according to the following reaction scheme 36.
[반응식 36][Reaction Scheme 36]
<중간체 7-b> <중간체 7-c><Intermediate 7-b> <Intermediate 7-c>
합성예 6-4에서 <중간체 6-c> 대신 <중간체 7-b>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <중간체 7-c> (26.4g, 70.1%)를 얻었다. Intermediate 7-c> (26.4 g, 70.1%) was obtained in the same manner except that <Intermediate 7-b> was used in place of <Intermediate 6-c> in Synthesis Example 6-4.
합성예Synthetic example 7-4. <화합물 7-4. <Compound 109>의109> 합성 synthesis
하기 반응식 37에 의하여 <화합물 109>를 합성하였다≪ Compound 109 > was synthesized according to the following Reaction Scheme 37
[반응식 37][Reaction Scheme 37]
<중간체 2-c> <중간체 7-c> <화합물 109><Intermediate 2-c> <Intermediate 7-c> <Compound 109>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 <중간체 2-c>를 사용하고 페닐보론산 대신 <중간체 7-c>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 109> (4.1g, 43.1%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-1, except that <Intermediate 2-c> was used instead of 4-bromo-2-iodobenzoate and <Intermediate 7-c> was used instead of phenylboronic acid, 109> (4.1 g, 43.1%).
MS (MALDI-TOF) : m/z 729.34[M+]MS (MALDI-TOF): m / z 729.34 [M < + >].
합성예Synthetic example 8. 화합물 125의 합성 8. Synthesis of Compound 125
합성예Synthetic example 8-1. <화합물 8-1. <Compound 125>의125> of 합성 synthesis
하기 반응식 38에 의하여 <화합물 125>를 합성하였다.<Compound 125> was synthesized by the following Reaction Scheme 38.
[반응식 38][Reaction Scheme 38]
<중간체 3-d> <중간체 7-c> <화합물 125><Intermediate 3-d> <Intermediate 7-c> <Compound 125>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 <중간체 3-d>를 사용하고 페닐보론산 대신 <중간체 7-c>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 125> (4.7g, 44.1%)을 얻었다. Synthesis was conducted in the same manner as in Synthesis Example 1-1, except that <Intermediate 3-d> was used instead of 4-bromo-2-iodobenzoate and <Intermediate 7-c> was used instead of phenylboronic acid, 125> (4.7 g, 44.1%).
MS (MALDI-TOF) : m/z 729.34[M+]MS (MALDI-TOF): m / z 729.34 [M < + >].
합성예Synthetic example 9. 화합물 129의 합성 9. Synthesis of Compound 129
합성예Synthetic example 9-1. <화합물 9-1. <Compound 129>의129> 합성 synthesis
하기 반응식 39에 의하여 <화합물 129>를 합성하였다.<Compound 129> was synthesized by the following Reaction Scheme 39.
[반응식 39][Reaction Scheme 39]
<중간체 1-f> <화합물 129><Intermediate 1-f> <Compound 129>
합성예 1-1에서 4-브로모-2-아이오도벤조에이트 대신 <중간체 1-f>를 사용하고 페닐보론산 대신 (9-페닐-9H-카바졸-3-일)보론산을 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 129> (3.7g, 38.1%)을 얻었다. Intermediate 1-f> was used instead of 4-bromo-2-iodobenzoate in Synthesis Example 1-1 and (9-phenyl-9H-carbazol-3-yl) boronic acid was used in place of phenylboronic acid , The compound (129) (3.7 g, 38.1%) was obtained.
MS (MALDI-TOF) : m/z 535.23[M+]MS (MALDI-TOF): m / z 535.23 [M < + >
합성예Synthetic example 10. 화합물 141의 합성 10. Synthesis of Compound 141
합성예Synthetic example 10-1. <중간체 10-a>의 합성 10-1. Synthesis of <Intermediate 10-a>
하기 반응식 40에 의하여 <중간체 10-a>를 합성하였다.≪ Intermediate 10-a >
[반응식 40] [Reaction Scheme 40]
<화합물 129> <중간체 10-a> ≪ Compound 129 > < Intermediate 10-a &
합성예 3-4에서 <중간체 3-c> 대신 <화합물 129>를 사용한 것을 제외하고는 동일한 방법을 사용하여 <중간체 10-a> (11.5g, 80%)를 얻었다. <Intermediate 10-a> (11.5 g, 80%) was obtained using the same method except that <compound 129> was used in place of <intermediate 3-c> in Synthesis Example 3-4.
합성예Synthetic example 10-2. <화합물 10-2. <Compound 141>의141> 합성 synthesis
하기 반응식 41에 의하여 <화합물 141>을 합성하였다.<Compound 141> was synthesized by the following Reaction Scheme 41.
[반응식 41][Reaction Scheme 41]
<중간체 10-a> <중간체 7-a> <화합물 141><Intermediate 10-a> <Intermediate 7-a> <Compound 141>
합성예 6-3에서 <중간체 6-b> 대신 <중간체 7-a>를 사용하고 4-브로모 아이오도벤젠 대신 <중간체 10-a>를 사용한 것을 제외하고는 동일한 방법으로 합성하여 <화합물 141> (5.1g, 41.4%)을 얻었다. Synthesis Example 6-3 was repeated except that <Intermediate 7-a> was used instead of <Intermediate 6-b> and Intermediate 10-a> was used instead of 4-bromoiodobenzene to obtain Compound 141 > (5.1 g, 41.4%).
MS (MALDI-TOF) : m/z 894.4[M+]MS (MALDI-TOF): m / z 894.4 [M < + >].
실시예Example 1 ~ 5: 유기발광소자의 1 to 5: Organic light emitting device 제조(ETL) 전자Manufacturing (ETL) Electronics 수송층Transport layer 용도 Usage
ITO 글래스의 발광 면적이 2 mm x 2 mm 크기가 되도록 패터닝 한 후 세정하였다. 기판을 진공 챔버에 장착한 후 베이스 압력이 1x10-6 torr가 되도록 한 후 유기물을 상기 ITO위에 HATCN(50Å), NPD(650Å), 청색 호스트(BH)+ 청색 도판트(BD) 5% 로 도핑하여 200Å 두께의 발광층을 형성하였다. 다음으로 전자수송층의 용도로서 하기 표 1에 기재된 본 발명에 의해 제조된 화합물 : Liq = 1:1 (300Å), 전자 주입층으로 Liq(10Å), Al(1,000Å)의 순서로 성막 하였으며, 0.4 mA에서 측정을 하였다. 상기 [HATCN], [NPD], [BH], [BD], [Liq] 의 구조는 다음과 같다The ITO glass was patterned to have a light emitting area of 2 mm x 2 mm and then cleaned. After the substrate was mounted in a vacuum chamber, the base pressure was adjusted to 1 × 10 -6 torr. Then, the organic material was doped on the ITO with HATCN (50 Å), NPD (650 Å), blue host (BH) + blue dopant To form a light-emitting layer having a thickness of 200 ANGSTROM. Liq (1: 1) (300 Å), Liq (10 Å), and Al (1,000 Å) were used as the electron transport layer in the following order: 0.4 mA. The structures of [HATCN], [NPD], [BH], [BD], and [Liq] are as follows
[HATCN] [NPD] [BD][HATCN] [NPD] [BD]
[BH] [Liq] [BH] [Liq]
비교예Comparative Example 1 One
비교예 1을 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 본 발명에 의해 제조된 화합물 대신 일반적으로 전자수송층 물질로 많이 사용되고 있는 ET를 사용한 점을 제외하고 동일하게 제작하였으며 상기 ET 의 구조는 아래와 같다.The organic light emitting diode device for Comparative Example 1 was fabricated in the same manner except that ET, which is generally used as an electron transport layer material, was used instead of the compound manufactured by the present invention in the device structure of the above embodiment. same.
[ET] [ET]
한편, 본 발명에서의 실시예 1 내지 5, 비교예 1 에 따라 제조된 제조된 유기발광소자에 대하여, 전압, 전류, 휘도, 색 좌표 및 수명을 측정하고 그 결과를 하기 [표 1]에 나타내었다. T95은 휘도가 초기 휘도(2000 cd/m2)에 비해 95%로 감소되는데 소요되는 시간을 의미한다The voltage, current, luminance, color coordinates, and lifetime of the organic light-emitting device manufactured according to Examples 1 to 5 and Comparative Example 1 of the present invention were measured, and the results are shown in Table 1 below. . T95 means the time required for the luminance to be reduced to 95% compared to the initial luminance (2000 cd / m 2 )
상기 표 1에서 보는 바와 같이 본 발명에 의하여 확보된 유기화합물은 종래기술에 따라 전자수송층 재료로 많이 쓰이는 ET에 비하여 높은 효율, 낮은 구동전압 및 장수명을 가진다.As shown in Table 1, the organic compound obtained according to the present invention has higher efficiency, lower driving voltage and longer life than ET, which is widely used as an electron transport layer material according to the prior art.
실시예Example 6 ~ 10: 유기발광소자의 6 to 10: 제조(HTL) 정공Manufacturing (HTL) Precision 수송층Transport layer 용도 Usage
ITO 글래스의 발광 면적이 2 mm x 2 mm 크기가 되도록 패터닝한 후 세정하였다. 기판을 진공 챔버에 장착한 후 베이스 압력이 1x10-6 torr가 되도록 한 후 유기물을 상기 ITO위에 HATCN(50Å), 정공수송층으로서, 하기 표 2에 기재된 본 발명에 의해 제조된 화합물(650Å), 청색 호스트(BH)+ 청색 도판트(BD) 5% 로 도핑하여 200Å 두께의 발광층을 형성하였다. 이후에 전자수송층으로서, 화합물 ET :Liq = 1:1 (300Å), 전자 주입층으로서 Liq(10Å), Al(1,000Å)의 순서로 성막 하였으며, 0.4 mA에서 측정을 하였다. 상기 [HATCN], [ET], [BD], [BH], [Liq] 의 구조는 다음과 같다.The ITO glass was patterned to have a light emitting area of 2 mm x 2 mm and then cleaned. After the substrate was mounted in a vacuum chamber and the base pressure was adjusted to 1 × 10 -6 torr, an organic material was coated on the ITO using HATCN (50 Å) as the hole transport layer, the compound (650 Å) Doped with a host (BH) + blue dopant (BD) of 5% to form a 200 Å thick light emitting layer. Thereafter, the compound ET: Liq = 1: 1 (300 ANGSTROM), the electron injecting layer Liq (10 ANGSTROM) and Al (1,000 ANGSTROM) were sequentially deposited as the electron transporting layer. The structures of [HATCN], [ET], [BD], [BH] and [Liq] are as follows.
[HATCN] [ET] [BD][HATCN] [ET] [BD]
[BH] [Liq] [BH] [Liq]
비교예Comparative Example 2 2
비교예 2를 위한 유기발광다이오드 소자는 상기 실시예 6 내지 10의 소자구조에서 본 발명에 의해 제조된 화합물 대신 종래기술에서 일반적인 정공수송층 물질로 많이 사용되고 있는 NPD를 사용한 점을 제외하고 동일하게 제작하였으며 상기 NPD 의 구조는 아래와 같다.The organic light-emitting diode device for Comparative Example 2 was fabricated in the same manner as in Examples 6 to 10 except that NPD, which is widely used as a hole transport layer material in the prior art, was used instead of the compound prepared by the present invention The structure of the NPD is as follows.
[NPD] [NPD]
상기 실시예 6 내지 10, 비교예 2 에 따라 제조된 제조된 유기발광소자에 대하여, 전압, 전류, 휘도, 색 좌표 및 수명을 측정하고 그 결과를 하기 [표 2]에 나타내었다. T95은 휘도가 초기 휘도(2000 cd/m2)에 비해 95%로 감소되는데 소요되는 시간을 의미한다The voltage, current, luminance, color coordinates, and lifetime of the organic light-emitting device manufactured according to Examples 6 to 10 and Comparative Example 2 were measured, and the results are shown in Table 2 below. T95 means the time required for the luminance to be reduced to 95% compared to the initial luminance (2000 cd / m 2 )
상기 표 2에서 보는 바와 같이 본 발명에 의하여 확보된 유기화합물은 정공수송층 재료로 많이 쓰이는 NPD에 비하여 높은 효율, 낮은 구동전압 및 장수명을 가진다.As shown in Table 2, the organic compound obtained according to the present invention has higher efficiency, lower driving voltage and longer life time than NPD, which is widely used as a hole transport layer material.
Claims (18)
[화학식 A]
[화학식 B]
상기 [화학식 A] 및 [화학식 B]에서,
상기 치환기 R1 내지 R14는 각각 동일하거나 상이하고, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬아민기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴아민기, 치환 또는 비치환된 탄소수 6 내지 50의 아릴기, 치환 또는 비치환된 탄소수 7 내지 50의 아릴알킬기, 치환 또는 비치환되고 이종원자로 O, N 또는 S를 갖는 탄소수 2 내지 50의 헤테로아릴기, 시아노기, 니트로기, 할로겐기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 6 내지 24의 아릴실릴기, 치환 또는 비치환된 게르마늄기, 치환 또는 비치환된 붕소기, 치환 또는 비치환된 알루미늄기, 카르보닐기, 포스포릴기, 아미노기, 싸이올기, 히드록시기, 셀레늄기, 텔루륨기, 아미드기, 에테르기 및 에스테르기 중에서 선택되는 어느 하나이고,
각각 서로 인접하는 치환기와 연결되어 지환족, 방향족의 단일환 또는 다환 고리를 형성할 수 있으며, 상기 형성된 지환족, 방향족의 단일환 또는 다환 고리의 탄소원자는 N, S, O 중에서 선택되는 어느 하나 이상의 헤테로원자로 치환될 수 있으며,
상기 [화학식 A] 에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A1 과 결합하는 단일결합이고
상기 [화학식 B]에서, 치환기 R1 내지 R12 중 하나 또는 두개의 치환기는 상기 A2와 결합하는 단일결합이며, 상기 A2내 Ar2와 L2는 서로 연결되어 축합고리를 형성할 수 있고, 또한 Ar3 과 L2는 서로 연결되어 축합고리를 형성할 수 있으며,
상기 연결기 L1 및 L2는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 1 내지 60의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알케닐렌기, 치환 또는 비치환된 탄소수 2 내지 60의 알키닐렌기, 치환 또는 비치환된 탄소수 3 내지 60의 시클로 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 60의 헤테로시클로알킬렌기, 치환 또는 비치환된탄소수 6 내지 60의 아릴렌기 또는 치환 또는 비치환된탄소수 2 내지 60의 헤테로아릴렌기 중에서 선택되는 어느 하나이며;
n 및 m은 각각 동일하거나 상이하며, 서로 독립적으로 0 내지 3의 정수이되, 이들 각각이 2 이상인 경우에 각각의 연결기 L1 및 L2는 서로 동일하거나 상이하고,
상기 Ar1 내지 Ar3는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 6 내지 40의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기, 치환 또는 비치환된 탄소수 1 내지 40의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기 중에서 선택되는 어느 하나이고,
여기서, 상기‘치환 또는 비치환된’에서의 ‘치환’은 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 2 내지 24의 알케닐기, 탄소수 2 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 7 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내지 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 6 내지 24의 아릴실릴기, 탄소수 6 내지 24의 아릴옥시기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환되는 것을 의미한다. An organic compound represented by the following formula (A) or (B).
(A)
[Chemical Formula B]
In the above formulas (A) and (B)
The substituents R 1 to R 14 are the same or different and are each independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, A substituted or unsubstituted C1 to C30 alkoxy group, a substituted or unsubstituted C2 to C30 alkynyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C5 to C30 cycloalkenyl group, A substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkylthioxy group having 1 to 30 carbon atoms, a substituted or unsubstituted arylthioxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms A substituted or unsubstituted arylamine group having 6 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl group having 7 to 50 carbon atoms, , A substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms having O, N or S as a hetero atom, a cyano group, a nitro group, a halogen group, an alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 6 to 24 carbon atoms , A substituted or unsubstituted germanium group, a substituted or unsubstituted boron group, a substituted or unsubstituted aluminum group, a carbonyl group, a phosphoryl group, an amino group, a thiol group, a hydroxyl group, a selenium group, a tellurium group, An ester group,
And the carbon atom of the formed alicyclic or aromatic monocyclic or polycyclic ring may be any one or more selected from N, S, and O, and the carbon atom of the alicyclic or aromatic monocyclic or polycyclic ring may form a monocyclic or polycyclic ring of alicyclic or aromatic, Which may be substituted by a heteroatom,
In the above formula (A), one or two substituents of the substituents R 1 to R 12 are a single bond which binds to the above-mentioned Al
In the above formula (B), one or two substituents of the substituents R 1 to R 12 are a single bond bonding to the A 2, Ar 2 and L 2 in the A 2 may be connected to each other to form a condensed ring, and Ar 3 and L 2 They may be connected to each other to form a condensed ring,
The linking groups L 1 and L 2 are the same or different and independently represent a substituted or unsubstituted alkylene group having 1 to 60 carbon atoms, a substituted or unsubstituted alkenylene group having 2 to 60 carbon atoms, a substituted or unsubstituted C2- A substituted or unsubstituted C2-C60 alkynylene group, a substituted or unsubstituted C3-C60 cycloalkylene group, a substituted or unsubstituted C2-C60 heterocycloalkylene group, a substituted or unsubstituted C6-C60 arylene group, And an unsubstituted heteroarylene group having 2 to 60 carbon atoms;
n and m are the same or different and independently of each other an integer of 0 to 3, and when each of these is 2 or more, each of the linking groups L1 and L2 is the same or different from each other,
Each of Ar 1 to Ar 3 is the same or different and independently represents a substituted or unsubstituted aryl group having 6 to 40 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms, a substituted or unsubstituted aryl group having 1 to 40 carbon atoms A substituted or unsubstituted alkyl group having 3 to 30 carbon atoms, and a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms,
The 'substituted' in the 'substituted or unsubstituted' may be a substituent selected from the group consisting of deuterium, a cyano group, a halogen group, a hydroxy group, a nitro group, an alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, An alkenyl group, an alkynyl group having 2 to 24 carbon atoms, a heteroalkyl group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, an arylalkyl group having 7 to 24 carbon atoms, a heteroaryl group having 2 to 24 carbon atoms, An alkyl group having 1 to 24 carbon atoms, an alkylamino group having 1 to 24 carbon atoms, an arylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, an alkylsilyl group having 1 to 24 carbon atoms, An aryloxy group, an aryloxy group, an arylsilyl group, and an aryloxy group having 6 to 24 carbon atoms.
상기 치환기 Ar1 내지 Ar3는 각각 동일하거나 상이하고, 서로 독립적으로 비치환된 탄소수 6 내지 30의 아릴기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기 중에서 선택되는 어느 하나인 것을 특징으로 하는 유기 화합물. The method according to claim 1,
Wherein the substituents Ar1 to Ar3 are the same or different and are each independently any one selected from the group consisting of an unsubstituted aryl group having 6 to 30 carbon atoms and a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms. compound.
상기 치환기 R13 및 R14는 각각 동일하거나 상이하고, 서로 독립적으로 치환 또는 비치환된 탄소수 1 내지 20의 알킬기, 또는 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 인 것을 특징으로 하는 유기 화합물. The method according to claim 1,
Wherein the substituents R13 and R14 are the same or different and are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms.
상기 [화학식 A]내 Ar1은 치환 또는 비치환된 탄소수 2 내지 30의 헤테로아릴기 인 것을 특징으로 하는 유기 화합물. The method according to claim 1,
Wherein Ar 1 in the above [Formula A] is a substituted or unsubstituted heteroaryl group having 2 to 30 carbon atoms.
상기 [화학식 A]내 치환기 Ar1은 하기 구조식 A 내지 구조식 Q에서 선택되는 어느 하나인 것을 특징으로 하는 유기 화합물.
[구조식 A] [구조식 B] [구조식 C]
[구조식 D] [구조식 E] [구조식 F]
[구조식 G] [구조식 H] [구조식 I]
[구조식 J] [구조식 K] [구조식 L]
[구조식 M] [구조식 N] [구조식 O]
[구조식 P] [구조식 Q]
상기 구조식 A 내지 구조식 Q내 치환기 R은 제1항에서 정의된 R1 내지 R14와 동일하며,
상기 k는 1 내지 7의 정수이되, k가 2 이상인 경우에 각각의 R은 동일하거나 상이하며,
k가 2 이상인 경우에 각각의 치환기 R은 서로 인접하는 치환기 R과 결합되어 포화 또는 불포화 고리를 형성할 수 있다. 5. The method of claim 4,
Wherein the substituent Ar1 in the formula [A] is any one selected from the following structural formulas A to Q:
[Structural formula A] [Structural formula B] [Structural formula C]
[Structural formula D] [Structural formula E] [Structural formula F]
[Structural formula G] [Structural formula H] [Structural formula I]
[Structural formula J] [Structural formula K] [Structural formula L]
[Structural formula M] [Structural formula N] [Structural formula O]
[Structural formula P] [Structural formula Q]
The substituents R in the structural formulas A to Q are the same as those of R 1 to R 14 defined in claim 1,
K is an integer of 1 to 7, and when k is 2 or more, each R is the same or different,
When k is 2 or more, each substituent R may be bonded to adjacent substituent R to form a saturated or unsaturated ring.
상기 화학식 A 및 화학식 B에서, 상기 치환기 R1 내지 R4중 하나가 A1 또는 A2와 결합하는 단일결합 인 것을 특징으로 하는 유기 화합물.The method according to claim 1,
Wherein one of the substituents R 1 to R 4 is a single bond bonded to A 1 or A 2 in the above formulas (A) and (B).
상기 화학식 A 및 화학식 B에서, 상기 치환기 R5 내지 R12중 하나가 A1 또는 A2와 결합하는 단일결합 인 것을 특징으로 하는 유기 화합물.The method according to claim 1,
Wherein in the above formulas A and B, one of the substituents R5 to R12 is a single bond bonding with Al or A2.
상기 화학식 B에서 Ar2 및 Ar3는 각각 동일하거나 상이하며, 서로 독립적으로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기인 것을 특징으로 하는 유기 화합물.The method according to claim 1,
In the formula (B), Ar2 and Ar3 are the same or different and independently of each other, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
상기 치환기 R1 내지 R12 중 상기 A1 또는 A2와 연결되지 않는 치환기는 수소 또는 중수소 인 것을 특징으로 하는 유기 화합물.The method according to claim 1,
Wherein the substituent which is not connected to A1 or A2 among the substituents R1 to R12 is hydrogen or deuterium.
상기 연결기 L1 및 L2는 서로 동일하거나 상이하며, 각각 독립적으로 단일결합이거나, 아래 구조식 1 내지 구조식 9 중에서 선택되는 어느 하나인 것을 특징으로 하는 유기 화합물.
[구조식 1] [구조식 2] [구조식 3] [구조식 4]
[구조식 5] [구조식 6] [구조식 7]
[구조식 8] [구조식 9]
상기 구조식1 내지 구조식 9에서 방향족 고리의 탄소자리는 수소 또는 중수소가 결합된다. The method according to claim 1,
Wherein the linking groups L 1 and L 2 are the same or different and are each independently a single bond or any one selected from the following structural formulas 1 to 9.
[Structural Formula 1] [Structural Formula 2] [Structural Formula 3] [Structural Formula 4]
[Structural formula 5] [Structural formula 6] [Structural formula 7]
[Structural formula 8] [Structural formula 9]
In the structural formulas 1 to 9, the carbon of the aromatic ring is bonded to hydrogen or deuterium.
상기 [화학식 A] 에서, 치환기 R1 내지 R12 중 하나의 치환기만이 상기 A1 과 결합하는 단일결합인 것을 특징으로 하는 유기 화합물.The method according to claim 1,
In the above formula (A), only one substituent of the substituents R 1 to R 12 is a single bond which binds to the above-mentioned Al.
상기 [화학식 A] 또는 [화학식 B]로 표시되는 화합물은 하기 [화합물 1] 내지 [화합물 144]로 표시되는 군으로부터 선택된 어느 하나인 것을 특징으로 하는 유기 화합물.
[화합물 1] [화합물 2] [화합물 3] [화합물 4]
[화합물 5] [화합물 6] [화합물 7] [화합물 8]
[화합물 9] [화합물 10] [화합물 11] [화합물 12]
[화합물 13] [화합물 14] [화합물 15] [화합물 16]
[화합물 17] [화합물 18] [화합물 19] [화합물 20]
[화합물 21] [화합물 22] [화합물 23] [화합물 24]
[화합물 25] [화합물 26] [화합물 27] [화합물 28]
[화합물 29] [화합물 30] [화합물 31] [화합물 32]
[화합물 33] [화합물 34] [화합물 35] [화합물 36]
[화합물 37] [화합물 38] [화합물 39] [화합물 40]
[화합물 41] [화합물 42] [화합물 43] [화합물 44]
[화합물 45] [화합물 46] [화합물 47] [화합물 48]
[화합물 49] [화합물 50] [화합물 51] [화합물 52]
[화합물 53] [화합물 54] [화합물 55] [화합물 56]
[화합물 57] [화합물 58] [화합물 59] [화합물 60]
[화합물 61] [화합물 62] [화합물 63] [화합물 64]
[화합물 65] [화합물 66] [화합물 67] [화합물 68]
[화합물 69] [화합물 70] [화합물 71] [화합물 72]
[화합물 73] [화합물 74] [화합물 75] [화합물 76]
[화합물 77] [화합물 78] [화합물 79] [화합물 80]
[화합물 81] [화합물 82] [화합물 83] [화합물 84]
[화합물 85] [화합물 86] [화합물 87] [화합물 88]
[화합물 89] [화합물 90] [화합물 91] [화합물 92]
[화합물 93] [화합물 94] [화합물 95] [화합물 96]
[화합물 97] [화합물 98] [화합물 99] [화합물 100]
[화합물 101] [화합물 102] [화합물 103] [화합물 104]
[화합물 105] [화합물 106] [화합물 107] [화합물 108]
[화합물 109] [화합물 110] [화합물 111] [화합물 112]
[화합물 113] [화합물 114] [화합물 115] [화합물 116]
[화합물 117] [화합물 118] [화합물 119] [화합물 120]
[화합물 121] [화합물 122] [화합물 123] [화합물 124]
[화합물 125] [화합물 126] [화합물 127] [화합물 128]
[화합물 129] [화합물 130] [화합물 131] [화합물 132]
[화합물 133] [화합물 134] [화합물 135] [화합물 136]
[화합물 137] [화합물 138] [화합물 139] [화합물 140]
[화합물 141] [화합물 142] [화합물 143] [화합물 144]The method according to claim 1,
Wherein the compound represented by the above formula (A) or (B) is any one selected from the group consisting of the following compounds [1] to [144].
[Compound 1] [Compound 2] [Compound 3] [Compound 4]
[Compound 5] [Compound 6] [Compound 7] [Compound 8]
[Compound 9] [Compound 10] [Compound 11] [Compound 12]
[Compound 13] [Compound 14] [Compound 15] [Compound 16]
[Compound 17] [Compound 18] [Compound 19] [Compound 20]
[Compound 21] [Compound 22] [Compound 23] [Compound 24]
[Compound 25] [Compound 26] [Compound 27] [Compound 28]
[Compound 29] [Compound 30] [Compound 31] [Compound 32]
[Compound 33] [Compound 34] [Compound 35] [Compound 36]
[Compound 37] [Compound 38] [Compound 39] [Compound 40]
[Compound 41] [Compound 42] [Compound 43] [Compound 44]
[Compound 45] [Compound 46] [Compound 47] [Compound 48]
[Compound 49] [Compound 50] [Compound 51] [Compound 52]
[Compound 53] [Compound 54] [Compound 55] [Compound 56]
[Compound 57] [Compound 58] [Compound 59] [Compound 60]
[Compound 61] [Compound 62] [Compound 63] [Compound 64]
[Compound 65] [Compound 66] [Compound 67] [Compound 68]
[Compound 69] [Compound 70] [Compound 71] [Compound 72]
[Compound 73] [Compound 74] [Compound 75] [Compound 76]
[Compound 77] [Compound 78] [Compound 79] [Compound 80]
[Compound 81] [Compound 82] [Compound 83] [Compound 84]
[Compound 85] [Compound 86] [Compound 87] [Compound 88]
[Compound 89] [Compound 90] [Compound 91] [Compound 92]
[Compound 93] [Compound 94] [Compound 95] [Compound 96]
[Compound 97] [Compound 98] [Compound 99] [Compound 100]
[Compound 101] [Compound 102] [Compound 103] [Compound 104]
[Compound 105] [Compound 106] [Compound 107] [Compound 108]
[Compound 109] [Compound 110] [Compound 111] [Compound 112]
[Compound 113] [Compound 114] [Compound 115] [Compound 116]
[Compound 117] [Compound 118] [Compound 119] [Compound 120]
[Compound 121] [Compound 122] [Compound 123] [Compound 124]
[Compound 125] [Compound 126] [Compound 127] [Compound 128]
[Compound 129] [Compound 130] [Compound 131] [Compound 132]
[Compound 133] [Compound 134] [Compound 135] [Compound 136]
[Compound 137] [Compound 138] [Compound 139] [Compound 140]
[Compound 141] [Compound 142] [Compound 143] [Compound 144]
상기 제1전극에 대향된 제2전극; 및
상기 제1전극과 상기 제2전극 사이에 개재되는 유기층;을 포함하는 유기발광소자로서,
상기 유기층이 제1항 내지 제12항 중 어느 한 항에 기재된 유기 화합물을 포함하는 것을 특징으로 하는 유기발광소자. A first electrode;
A second electrode facing the first electrode; And
And an organic layer interposed between the first electrode and the second electrode,
Wherein the organic layer comprises the organic compound according to any one of claims 1 to 12.
상기 유기발광소자 내 유기층은 정공 주입층, 정공 수송층, 정공 주입 기능 및 정공 수송 기능을 동시에 갖는 기능층, 발광층, 전자 수송층, 및 전자 주입층 중 적어도 하나를 포함하는 것을 특징으로 하는 유기 발광 소자.14. The method of claim 13,
Wherein the organic layer in the organic light emitting device comprises at least one of a hole injecting layer, a hole transporting layer, a functional layer having both a hole injecting function and a hole transporting function, a light emitting layer, an electron transporting layer, and an electron injecting layer.
상기 유기 화합물은 정공 수송층 용도로 사용하는 것을 특징으로 하는 유기 발광 소자. 14. The method of claim 13,
Wherein the organic compound is used for a hole transport layer.
상기 유기유기화합물은 전자 수송층 용도로 사용하는 것을 특징으로 하는 유기 발광 소자.14. The method of claim 13,
Wherein the organic organic compound is used for an electron transport layer.
상기 각각의 층중에서 선택된 하나 이상의 층은 증착공정 또는 용액공정에 의해 형성되는 것을 특징으로 하는 유기 발광 소자.15. The method of claim 14,
Wherein at least one layer selected from the respective layers is formed by a deposition process or a solution process.
상기 유기발광소자는 평판 디스플레이 장치; 플렉시블 디스플레이 장치; 단색 또는 백색의 평판 조명용 장치; 및, 단색 또는 백색의 플렉시블 조명용 장치;에서 선택되는 어느 하나의 장치에 사용되는 것을 특징으로 하는 유기 발광 소자.
14. The method of claim 13,
The organic light emitting device includes a flat panel display device; A flexible display device; Monochrome or white flat panel illumination devices; And a device for flexible illumination of a single color or a white color.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160098513A KR102637956B1 (en) | 2016-08-02 | 2016-08-02 | Novel organic compounds derivatives and organic light-emitting diode therewith |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160098513A KR102637956B1 (en) | 2016-08-02 | 2016-08-02 | Novel organic compounds derivatives and organic light-emitting diode therewith |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180014985A true KR20180014985A (en) | 2018-02-12 |
KR102637956B1 KR102637956B1 (en) | 2024-02-19 |
Family
ID=61225184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160098513A KR102637956B1 (en) | 2016-08-02 | 2016-08-02 | Novel organic compounds derivatives and organic light-emitting diode therewith |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102637956B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108424344A (en) * | 2018-04-11 | 2018-08-21 | 华南协同创新研究院 | Monomer and polymer containing luxuriant and rich with fragrance five yuan and ring element and the preparation method and application thereof |
CN109400487A (en) * | 2018-11-12 | 2019-03-01 | 长春海谱润斯科技有限公司 | A kind of fluorene kind derivative and its organic electroluminescence device |
CN110563638A (en) * | 2018-06-05 | 2019-12-13 | 上海嵘彩光电材料有限公司 | compound and organic electronic device thereof |
CN112624961A (en) * | 2020-12-31 | 2021-04-09 | 阜阳欣奕华材料科技有限公司 | Carbazole compound, organic electroluminescent device and display device |
WO2021230655A1 (en) * | 2020-05-13 | 2021-11-18 | 주식회사 엘지화학 | Novel compound and organic light-emitting element comprising same |
KR20210139176A (en) * | 2020-05-13 | 2021-11-22 | 주식회사 엘지화학 | Novel compound and organic light emitting device comprising the same |
US11917914B1 (en) * | 2020-10-26 | 2024-02-27 | Duk San Neolux Co., Ltd. | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
CN115135643B (en) * | 2020-05-13 | 2024-04-30 | 株式会社Lg化学 | Compound and organic light emitting device including the same |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100059653A (en) * | 2008-11-26 | 2010-06-04 | 다우어드밴스드디스플레이머티리얼 유한회사 | Electroluminescent device using the electroluminescent compounds |
JP2010168363A (en) | 2008-12-25 | 2010-08-05 | Chisso Corp | Anthracene derivative having pyridylnaphthyl group and organic electroluminescent device |
KR20100112903A (en) * | 2009-04-10 | 2010-10-20 | 주식회사 엘지화학 | New compounds and organic electronic device using the same |
KR101074193B1 (en) | 2008-08-22 | 2011-10-14 | 주식회사 엘지화학 | Organic electronic device material and organic electronic device using the same |
KR20120104204A (en) | 2009-11-12 | 2012-09-20 | 호도가야 가가쿠 고교 가부시키가이샤 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent element |
KR20140078096A (en) * | 2012-12-17 | 2014-06-25 | 에스에프씨 주식회사 | Aromatic amine derivatives having fluorenyl moiety and organic light-emitting diode including the same |
KR101455156B1 (en) | 2012-11-13 | 2014-10-27 | 덕산하이메탈(주) | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
KR20150000398A (en) * | 2013-05-02 | 2015-01-02 | 에스에프씨 주식회사 | Phenanthrene derivatives and organic light emitting diodes comprising the derivatives |
KR20150110891A (en) * | 2014-03-20 | 2015-10-05 | 삼성디스플레이 주식회사 | Organic light emitting diode comprising the same |
-
2016
- 2016-08-02 KR KR1020160098513A patent/KR102637956B1/en active IP Right Grant
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101074193B1 (en) | 2008-08-22 | 2011-10-14 | 주식회사 엘지화학 | Organic electronic device material and organic electronic device using the same |
KR20100059653A (en) * | 2008-11-26 | 2010-06-04 | 다우어드밴스드디스플레이머티리얼 유한회사 | Electroluminescent device using the electroluminescent compounds |
JP2010168363A (en) | 2008-12-25 | 2010-08-05 | Chisso Corp | Anthracene derivative having pyridylnaphthyl group and organic electroluminescent device |
KR20100112903A (en) * | 2009-04-10 | 2010-10-20 | 주식회사 엘지화학 | New compounds and organic electronic device using the same |
KR20120104204A (en) | 2009-11-12 | 2012-09-20 | 호도가야 가가쿠 고교 가부시키가이샤 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent element |
KR101455156B1 (en) | 2012-11-13 | 2014-10-27 | 덕산하이메탈(주) | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
KR20140078096A (en) * | 2012-12-17 | 2014-06-25 | 에스에프씨 주식회사 | Aromatic amine derivatives having fluorenyl moiety and organic light-emitting diode including the same |
KR20150000398A (en) * | 2013-05-02 | 2015-01-02 | 에스에프씨 주식회사 | Phenanthrene derivatives and organic light emitting diodes comprising the derivatives |
KR20150110891A (en) * | 2014-03-20 | 2015-10-05 | 삼성디스플레이 주식회사 | Organic light emitting diode comprising the same |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108424344A (en) * | 2018-04-11 | 2018-08-21 | 华南协同创新研究院 | Monomer and polymer containing luxuriant and rich with fragrance five yuan and ring element and the preparation method and application thereof |
CN108424344B (en) * | 2018-04-11 | 2021-07-02 | 华南协同创新研究院 | Monomer and polymer containing phenanthrene five-membered ring-fused unit, and preparation method and application thereof |
CN110563638A (en) * | 2018-06-05 | 2019-12-13 | 上海嵘彩光电材料有限公司 | compound and organic electronic device thereof |
CN109400487A (en) * | 2018-11-12 | 2019-03-01 | 长春海谱润斯科技有限公司 | A kind of fluorene kind derivative and its organic electroluminescence device |
WO2021230655A1 (en) * | 2020-05-13 | 2021-11-18 | 주식회사 엘지화학 | Novel compound and organic light-emitting element comprising same |
KR20210139176A (en) * | 2020-05-13 | 2021-11-22 | 주식회사 엘지화학 | Novel compound and organic light emitting device comprising the same |
CN115135643A (en) * | 2020-05-13 | 2022-09-30 | 株式会社Lg化学 | Novel compound and organic light emitting device including the same |
CN115135643B (en) * | 2020-05-13 | 2024-04-30 | 株式会社Lg化学 | Compound and organic light emitting device including the same |
US11917914B1 (en) * | 2020-10-26 | 2024-02-27 | Duk San Neolux Co., Ltd. | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof |
CN112624961A (en) * | 2020-12-31 | 2021-04-09 | 阜阳欣奕华材料科技有限公司 | Carbazole compound, organic electroluminescent device and display device |
Also Published As
Publication number | Publication date |
---|---|
KR102637956B1 (en) | 2024-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102570160B1 (en) | Novel organic compounds and organic light-emitting diode therewith | |
CN109804043B (en) | Organic light emitting element having long life, low voltage and high efficiency characteristics | |
KR102122212B1 (en) | organic light-emitting diode with High efficiency | |
KR102383344B1 (en) | Novel organic light-emitting diode including antracene derivatives | |
KR20180037695A (en) | Organic light-emitting diode with long lifetime, low voltage and high efficiency | |
KR102637956B1 (en) | Novel organic compounds derivatives and organic light-emitting diode therewith | |
KR20160026661A (en) | Novel heterocyclic compounds and organic light-emitting diode including the same | |
KR102144446B1 (en) | Organic Compound for organic light emitting diode and an organic light emitting diode including the same with long life | |
KR20150070928A (en) | An electroluminescent compound and an electroluminescent device comprising the same | |
KR102176164B1 (en) | Organic Compound for organic light emitting diode and an organic light emitting diode including the same | |
KR20180031385A (en) | Novel organic compounds and organic light-emitting diode therewith | |
KR20180024306A (en) | Novel organic compounds and organic light-emitting diode therewith | |
KR102184351B1 (en) | Organic Compound for organic light emitting diode and an organic light emitting diode including the same with long life | |
KR102507585B1 (en) | Novel organic compounds derivatives and organic light-emitting diode therewith | |
KR102249278B1 (en) | Aromatic amine derivative and organic electroluminescent device comprising same | |
KR102215776B1 (en) | Novel heterocyclic compounds and organic light-emitting diode including the same | |
KR20180023511A (en) | Novel organic compounds and organic light-emitting diode therewith | |
KR20160089655A (en) | Novel heterocyclic compounds and organic light-emitting diode including the same | |
EP3754737A1 (en) | Organic compound for organic light emitting diode and organic light emitting diode including same | |
KR20160028737A (en) | An organoelectro luminescent compounds and organoelectro luminescent device using the same | |
KR20180037889A (en) | Novel organic compounds and organic light-emitting diode therewith | |
KR20160123561A (en) | Novel heterocyclic compounds and organic light-emitting diode including the same | |
KR102316391B1 (en) | Pyrene derivatives comprising heteroaryl amine groupand organic light-emitting diode including the same | |
KR20190006930A (en) | organic light-emitting diode with High efficiency | |
KR20140083898A (en) | An electroluminescent compound and an electroluminescent device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |